Determinants of Colorectal Cancer among Patients Attending Biet Jala Governmental Hospital: A Case-control Study by عيسى خالد محمود غروز & Issa Khaled Mahmoud Ghrouz
  
Deanship of Graduate Studies 
Al-Quds University 
 
 
 
 
 
 
Determinants of Colorectal Cancer among Patients Attending 
Biet Jala Governmental Hospital: A Case-control Study 
 
 
 
Issa Khaled Ghrouz 
 
 
 
M.Sc. Thesis 
 
 
 
Jerusalem – Palestine 
 
 
 
1440 - 2019 
Determinants of Colorectal Cancer among Patients Attending Biet Jala 
Governmental Hospital: A Case-control Study 
 
 
 
 
 
Prepared by: 
Issa Khaled Ghrouz 
 
 
 
B.Sc in Medical Laboratory Sciences /Al Quds University/ Palestine 
 
 
 
Supervisor: Dr. Nuha El Sharif 
 
 
A thesis submitted in partial fulfillment of requirement for the degree of 
Master of Public Health/School of Public Health/ Al-Quds University 
 
 
Jerusalem – Palestine 
1440 – 2019 
Deanship of Graduate Studies 
Al-Quds University 
School of Public Health 
Thesis approval 
Determinants of Colorectal Cancer among Patients Attending Biet Jala Governmental 
Hospital: A Case-control Study 
Prepared by: Issa Khaled Ghrouz 
Registration No.: 21411146 
Supervisor: Dr. Nuha El Sharif 
Master thesis submitted and accepted, Date: 28-5-2019. 
The names and signatures of the examining committee members are as follows: 
1. Head of committee Dr. Nuha El Sharif Signatur 
2. Internal examiner Dr. Khaldoun Bader Signature 
3. External examiner Dr. Azzam Salah Signatu-,~ 2\ ~ 
Jerusalem - Palestine 
1440 - 2019 
Dedication 
 
I dedicate this work to my dear parents. 
To my Grandparents 
To my uncle Dr Ibrahim 
To my beloved wife Aseel 
To my brothers and sisters 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

I 
 
 
ACKNOWLEDGMENT 
 
 
لمعلا اذه مامتإ ىلع ينناعأو ينقفو يذلا نيملاعلا بر لله دمحلا 
 
I would like to give my greatest appreciation to my supervisor, Dr. Nuha El Sharif, for her 
supervision, encouragement, guidance and patience throughout this study. 
 
I would like to express my thanks to the faculty of public health; Al-Quds University with 
its entire staff. 
 
My special thanks go to the BietJala Governmental Hospital staff for their cooperation and 
help during my data collection and sampling from the study subjects. 
 
I would like also to thank my entire family for their support throughout the study especially 
my parents, my uncle Dr Ibrahim Ghrouz and my brother PT Amer Ghrouz.  
 
I wish to express my gratitude to my friends Dr Samer Asad and Dr Akram Najjar and all 
my colleagues for their encouragement and endless support. 
 
Finally, I owe my deepest gratitude to my wife Aseel for her support, inspiration and 
patience throughout my master degree pursuing 
 
 
 
 
 
 
II 
 
Executive summary 
Background: In Palestine, colorectal cancer is the second most occurring cancer in 
following Lung cancer. It accounts for 9.9% of all cancer cases. This percentage is 
considered high when compared to the surrounding countries.  
Study problem and justification: There is no screening program for colorectal cancer in 
Palestine. Also, no study investigated the risk and the protective factors of colorectal 
cancer.  Therefore, we are planning this study to be a baseline study for decision makers 
to help in planning for a national strategy that can help in preventing this cancer and/or its 
complications.   
Aim & objectives: This study aims to identify the determinants of colorectal cancer among 
patients attending the oncology department at Biet Jala Governmental Hospital.  Its 
objectives are to determine the associations between the various lifestyle aspects, socio-
demographic characteristics, family history of malignancy factors, patients' health status, 
personal or family colon polyps, radiation therapy, and consanguinity with the risk of 
developing colorectal cancer. 
Study methodology: The study is a matched case control study. Study cases and control 
were matched by age and gender. The study consisted of 210 participants (105 cases and 
105 controls). Males composed 54% of the study population. Cases were Colorectal cancer 
patients attending the daycare and the oncology department at Beit Jala governmental 
hospital. Control were any other patients attending other hospital departments. All controls 
were tested for fecal occult blood test and all were negative. An interview-based 
questionnaire structured on the risk factors of colorectal cancer was used for data 
collection.  
Statistical Analysis: SPSS version 23 was used for data entry and analysis. Continuous 
variables were compared between the cases and controls by t test. Chi-square test was used 
for comparison of categorical variables between the two groups (cases and controls). 
Conditional logistic regression models were used in the multivariate analysis to generate 
the odds ratio. 
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Ethical Considerations: this study was submitted to Al Quds University-SPH graduate 
studies committee. Approval was obtained from the MOH to start the study at the hospital. 
A consent form was signed by cases and controls who agreed to participate in the study. 
Results: Analysis of the study cases data showed that the mean age of the participants was 
61±12 (mean ± SD) years, and the mean age of the cases at diagnosis was 59.5 years old. 
Of the cases 54% were males, 88.6% were married, 86.3% of were employed, 77.1% lived 
in the southern region of the West Bank, 63% of the cases lived in cities, and 92.4% of 
them were colon cancer patients only. 
On the other hand, analysis of control group data showed that the mean age of the 
participants was same as the cases dues to the age and gender matching. Of them 90.5% 
were married, 82.4 % were employed, 97.1% of them live in the southern region of the 
west bank, and 31.4% of them lived in cities while 62.9% of them lived in villages.   
The multivariate analysis showed that living in villages lowers the risk of colorectal cancer 
by 34%, while living in the southern region of the West Bank increases the risk of 
colorectal cancer by 12 folds (AOR= 12.439 CI= 2.724 – 56.809). Also, parental 
consanguinity almost triples the risk of colorectal (AOR=2.887 CI= 1.171- 7.118). 
Smoking increases the risk of colorectal cancer by 5.5 folds (AOR= 5.503 CI= 1.866-
16.227). Consuming fruits more than two meals a week reduces the risk of colorectal 
cancer by about 8 folds (AOR= 0.082 CI=0.032-0.206), while consuming grilled red meat 
increase the colorectal cancer risk (AOR= 2.847 CI= 1.289-6.287). Taking aspirin was 
associated with a reduced colorectal cancer risk with (AOR 0.248 CI= 0.099-0.621).  
Conclusion: This is one of the very few studies in Palestine that address the case of 
Colorectal cancer. Most studies were conducted on datasets that were collected from 
patient’s medical records. Our study used the classical matched case-control, which made 
it distinctive in its results. Our results confirmed the associations between red meat intake 
and smoking with colorectal cancer, but also, it showed that parental consanguinity, which 
is very common in the Arab societies, to be a risk factors for having this cancer. Also, 
aspirin intake and the consumption of fruits were shown as “protective” factors from 
colorectal cancer. Further longitudinal studies are needed on those at risk to develop 
colorectal cancer in order to be able to prevent such a fetal disease.   
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دراسة لدى المرضى المسجلين في مستشفى بيت جالا الحكومي: والمستقيم الاصابة بسرطان القولون محددات 
 الحالات والضوابط
 إعداد: عيسى خالد غروز
 إشراف: د. نهى الشريف
 
 الملخص
إن سرطان القولون والمستقيم يعد ثاني أكثر السرطانات انتشارا في فلسطين بعد سرطان الرئتين حيث  :خلفية الدراسة
 % من جميع السرطانات. وهذه النسبة تعتبر عالية مقارنتا بالدول المحيطة. 9.9يحتل ما نسبته 
م في مرضى السرطان تهدف هذه الدراسة لمعرفة محددات مرض سرطان القولون والمستقي: هدف الدراسة الرئيسي
الذين يتلقون العلاج في مستشفى بيت جالا الحكومي. كما تهدف هذه الدراسة لمعرفة العلاقة بين نمط الحياة، العوامل 
الاجتماعية والسكانية وتاريخ العائلة المرضي والحالة الصحية وزواج الأقارب وخطر الإصابة بمرض سرطان القولون 
 والمستقيم.
نمط هذه الدراسة هي دراسة للحالات والضوابط حيث تم مطابقة الحالات والضوابط بالعمر والجنس.  منهجية الدراسة:
حالة). الحالات جميعها كانت مرضى مصابين ومشخصين  501ضابط و 501مشترك ( 012تكونت هذه الدراسة من 
إما مرضى مقيمين في قسم الأورام أو مرضى يتلقون العلاج في العناية  امسبقا بمرض سرطان القولون والمستقيم وكانو
مرضى مقيمين في قسم من أقسام  اأي مرضى آخرين غير مرضى السرطانات سواء كانو االنهارية. الضوابط كانو
ضوابط مرضى العيادات الخارجية. تم عمل فحص الدم المخفي في البراز لجميع ال االمستشفى غير الأورام أو كانو
وكانت نتائجهم جميعا سلبية. ثم قام المشاركون في الدراسة بالإجابة على اسئلة الاستبيان المعد للدراسة عن طريق 
 مقابلتهم جميعا 
ففي المرحلة الأولى، تم حساب  .MBI-SSPS إدخال جميع البيانات وتحليلها باستخدام برنامج : تمالاحصائيالتحليل 
ت، وقد عرضت البيانات في جداول وأشكال بيانية، أما في المرحلة الثانية تم فحص العلاقة التكرارات لجميع المتغيرا
، كما تم حساب فحص  )50.0< p(عند مستوى الدلالة الاحصائية خطر عوامل ال والمستقيم وبين سرطان القولون 
والمجموعة الضابطة، كذلك تم  بين حالات الدراسة لرصد الاختلاف بين العوامل الخطية  )tset-t( العامل المستقل
في تحليل وحيد  ) 50.0< p( حساب نموذج الانحدار اللوجيستي المتعدد لجميع المتغيرات عند الدلالة الاحصائية
 %. 59للحصول على نسبة الترجيح ودرجة الثقة  المتغير
قدمت هذه الدراسة للجنة البحث العلمي والدراسات العليا في جامعة القدس. تم اخذ الموافقة للبدء الاعتبارات الأخلاقية: 
في الدراسة والعمل في المستشفى من وزارة الصحة الفلسطينية. قام جميع المشاركون في الدراسة بالموافقة على 
 المشاركة عن طريق التوقيع على نموذج موافقة. 
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عاما. حيث أحتل الذكور  16معلومات الدراسة أظهر أن معدل أعمار الحالات المشاركة في الدراسة هو تحليل : النتائج
% منهم يعيش في الجزء الجنوبي 1.77% منهم كان يعمل و3.68% منهم متزوجا و6.88% منهم وكان 45ما نسبته 
 مرضى سرطان قولون.  ا% كانو4.29% كان يعيش في المدن و36للضفة الغربية و
بالجهة المقابلة كان معدل أعمار ونسبة الذكور والإناث في الضوابط مطابق للحالات بسبب المطابقة المتبعة في الدراسة. 
% يعيش في المنطقة الجنوبية من الضفة 1.79يعملون و ا% منهم كانو4.28متزوجين و ا% منهم كانو5.09لكن 
 % منهم يعيش في المدن.4.13هم يعيش في قرى و% من9.26% منهم يعيش في المدن و4.13الغربية حيث كان 
وقد أظهرت نتائج تحليل نموذج الانحدار اللوجستي المتعدد أن سكان القرى أقل عرضة لخطر الإصابة بالمرض. 
ضعف عمن يسكنون  21وأظهرت أن السكن في المنطقة الجنوبية من الضفة الغربية يزيد خطر الإصابة بالمرض ب 
بمناطق اخرى. أيضا زواج الأقارب يزيد من خطر الإصابة بالمرض والتدخين يزيد من خطر الإصابة بالمرض بنسبة 
% مقارنة بالذين لا يدخنون. بالنسبة للعوامل الغذائية، أظهرت الدراسة أن الفواكه تقلل من خطر الإصابة بالمرض 055
 خطر الإصابة بالمرض. تناول الأسبيرين أيضا يقلل من خطر الإصابة بالمرض. ولكن اللحم الأحمر المشوي يزيد من
هذه واحدة من الدراسات القليلة في فلسطين التي تطرقت لموضوع مرض سرطان القولون والمستقيم. هذه : الخلاصة
 الدراسة هي دراسة للحالات والضوابط وهذا ما يجعلها مميزة بنتائجها.
 ين، أكل اللحم الأحمر، السكن في الجنوب، زواج الأقارب كلها تزيد من خطر الإصابة بالمرض.الدراسة أكدت أن التدخ
 وأظهرت أبضا ان تناول الأسبيرين والسكن في القرى وتناول الفاكهة كلها تقلل من خطر الإصابة بالمرض.
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Chapter One: Introduction 
1.1 Background 
Colorectal cancer (CRC), is any development of cancer from the colon or rectum (NCI, 
2018). It is also known as bowel cancer.  CRC may be diagnosed by taking a biopsy from 
the colon during a colonoscopy or sigmoidoscopy(NCI, 2018). Colorectal cancer treatment 
may include surgery, radiation therapy, chemotherapy and targeted therapy(NCI, 2018). 
However, Screening for the disease is still an important procedure for early detection and 
improvement of the prognosis. The main screening method used for CRC is the fecal occult 
blood test (FOBT). 
Colorectal Cancer is one of the major causes of morbidity and mortality worldwide. It is 
the third most common cancer in the world after lung and breast cancers, and the fourth in 
mortality (Wolf et al., 2018). It accounts for 9.7% of all cancer incidence in the world. It 
is estimated that 1.4 million new cases of colorectal cancer were diagnosed and 693,900 
deaths worldwide in 2012. Colorectal Cancer is the third most common cancer in men after 
lung and prostate cancers, and the second in women after breast cancer(WHO, 2012).   
Colorectal cancer is more common in the developed countries (Bener et al, 2011), where 
is accounts for over 63% of all colorectal cancer cases in the world, and its incidence rate 
is up to 10 times more in developed countries compared to the other countries(Haggar & 
Boushey, 2009). The highest incidence rates are found in Australia, New Zealand, Canada, 
the United States, and parts of Europe, where as the lowest rates are found in Africa, South-
Central Asia and South America(Haggar & Boushey, 2009).  
The incidence of colorectal cancer in the Arab world is low, despite its rank is second to 
breast cancer in some countries (Bener et al, 2009). In Palestine colorectal cancer ranks 
second to breast cancer as it composes 9.9% of all cancer cases (PHIC, 2016). This 
percentage is considered high in comparison to the Arab world and surrounding countries. 
For example, in Egypt it composes 4.4% and Jordan 9 % colorectal cancer cases of all 
cancers (Freedman et al, 2006).  
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Many factors have been found to be associated with or protective against colorectal cancer. 
About 70% of the colorectal cancer risk can be attributed to environmental factors (Saikali 
et al, 2004).  
Risk factors for colorectal cancer include diets that contains low fiber intake and high in 
fat, type 2 diabetes mellitus, high body mass index (BMI), physical inactivity, alcohol 
consumption and smoking (Frezza et al, 2006; Ulrich-Pur et al., 2001).  
On the other hand, some factors are protective against colorectal cancer that include:  
physical activity, younger age, higher education level, hormone replacement therapy, 
intake of calcium, vitamin D, folate, some antioxidant vitamins and minerals, nonsteroidal 
anti-inflammatory drugs NSAIDs and a diverse diet including yogurt and resistant starches 
(Slattery ML et al. 1997). Working to promote the protective factors such as quit smoking, 
eating a healthy diet and exercising may also help in preventing CRC. The low incidence 
of colorectal cancer in the Arab countries could be due to the dietary factors, with high 
intake of fruit and vegetables (Al-Shamsi et al., 2003). However, in Palestine no study 
investigated the risk factors for CRC. 
 
1.2 Study Justification 
Colon cancer is ranked second to breast cancer as the most common cancer among all 
cancers in Palestinian community with 9.9% of all reported cancer cases (PHIC, 2016). It 
is noticed that this prevalence percentage is higher than the surrounding countries. For 
example, CRC counts for 4.4% of all cancer cases in Egypt and 9% in Jordan (Freedman 
et al, 2006). CRC mortality in Palestine is the second among all cancer mortalities with 
13% of all cancer deaths (PHIC, 2016).  In the past 14 years, it was noticed that CRC 
incidence fluctuated but in the overall increased dramatically from 5.7% in 2000 to 
10.8%in 2013, and 9.9% in 2014 (PHIC, 2016). (See figure 1) 
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Figure 1: Percentage of reported CRC cases from all reported cancer cases in West 
Bank between years 2000-2014 (PHIC, 2016) 
 
To date, no study was conducted in Palestine that addresses the factors that contribute for 
this increase in the incidences over the past 10 years or investigated the risk factors for 
developing CRC.  
Services presented to CRC patients such as treatment and follow up are mainly offered in 
the cancer care centers distributed along the West Bank. BJGH in the central and the 
southern districts, and Al Watani governmental hospital in the northern districts are the two 
Ministry of health governed cancer care centers. On the other hand, Augusta Victoria 
Hospital in Jerusalem is a private referral hospital where certain services are presented to 
CRC patients. Treatment services including surgery, chemotherapy, and hormone therapy 
are delivered in the MOH governed cancer care centers. Since the radiation therapy is not 
available in the MOH governed cancer care centers, CRC patients who need such a 
treatment are referred to Augusta Victoria Hospital. CRC patients follow up are presented 
in the oncology clinics of the MOH governed cancer care centers. In some limited cases, 
the patient may be referred to neighboring countries to get the needed services.      
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However, there is no active screening or preventive program dealing with CRC in the 
Palestinian community. Hence, any research that focuses on the issue of CRC determinants 
would be of great value to help start establishing national programs dealing with the risk 
and protective factors of CRC. This study is a baseline study for decision makers to help 
in planning for a national strategy that can help in preventing this cancer and/or its 
complications.   
1.3 Problem Statement 
To our knowledge, no study has been carried out in Palestine to investigate the 
determinants and the risk factors of colorectal cancer.  As a result, there is no clear picture 
about the epidemiology of CRC in the Palestinian Community and the reasons for its 
increase in comparison to the Arab world.  
Therefore, it is very important to specify the factors that play a role as risk/protective 
factors among the Palestinian Community.  This data is not available in Palestine, which 
makes it a need. Results of this research will be a baseline for any future plans in the area 
of prevention, whether primary or secondary prevention, of CRC. 
1.4 Study Aim 
To identify the determinants of colorectal cancer among patients attending the oncology 
department at Biet Jala governmental hospital. 
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1.5 Study Objectives 
 
a. To determine the relationship between lifestyle factors such as diet, physical activity, 
obesity, alcohol consumption and smoking with colorectal cancer. 
b. To examine the association between various socio-demographic factors and 
occupational factors with colorectal cancer. 
c. To determine the association between patient’s health status such as diabetes and 
colorectal cancer. 
d. To investigate the association between family history of cancer and the occurrence of 
colorectal cancer.  
e. To investigate the association between personal or family colon polyps with the 
occurrence of colorectal cancer. 
f. To investigate the association between consanguinity marriage and the risk of 
colorectal cancer. 
 
1.6 Expected Outcome 
The study of the determinants and risk factors of CRC would increase the knowledge about 
these determinants and reveals the specific risk and protective factors in the Palestinian 
community, as well as addresses the risky groups. Thereafter, programs can be planned or 
implemented focusing directly on these risky groups and working on the specific risk and 
protective factors in the large community.  
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Chapter Two: Literature Review 
2.1 Introduction 
Literature showed that many factors are associated with colorectal cancer. Those factors 
are divided into:  Socio-demographic factors such as age and gender. Lifestyle factors 
such as smoking, alcohol consumption, diet, and physical activity, patient’s health status 
such as diabetes and hypertension., family history of colorectal cancer, personal and family 
history of colon polyps, and the relationship between consanguinity marriage and 
colorectal cancer. In this chapter, we are presenting the literature review concerning those  
factors.  
2.2 Socio-demographic risk factors 
Several epidemiological studies showed that age and sex as risk factors for increased risk 
of Colorectal cancer.  
2.2.1 Age 
Table 2.1 shows the studies that investigated the association between Age and CRC. 
A population-based study was carried out in Denmark to compare the relative risk of 
colorectal cancer among patients older than 75 years with that of younger patients during 
the period 1977 to 1999 found out that CRC is highly affected by age and there is a 
simultaneous increase in the rate of radical resection among elderly patients, reflecting 
more effective treatment, may underlie this finding (Iversen et al 2005).  
Another study was conducted in USA in 2014 to examine age-based colorectal cancer 
outcomes in an equal-access health care system (Steele et al 2014). The study examined 
7984 patients with equal health care access and resulted in young age at presentation (<50 
years) was associated with advanced stage and higher recurrence of colorectal cancer, but 
similar survival in comparison with older patients. Although increased adjuvant therapy 
use in younger patients may partially account for stage-specific increases in survival, the 
relative decreased chemotherapy use overall requires further evaluation (Steele et al 2014).  
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The World Cancer Research Fund and American Institute for Cancer Research Food, 
Nutrition, Physical Activity, and the Prevention of Cancer published in 2005 that the 
diagnosis of CRC increases after the age of 40, and highly rising after the age of 50 (WCRF, 
2007). More than 90% of colorectal cancer cases occur in people aged 50 or older (WCRF, 
2007). 
A prospective cohort study was conducted on 2942 patients in Japan between 1995 and 
1998 showed that the frequency of colon cancer increases with age (Okamoto et al., 2002).  
Another prospective cohort study in the US was conducted to assess the relationship 
between body Mass Index, Physical Activity, and Colorectal Cancer Risk Associated with β-
Catenin (CTNNB1) Status (Morikawa et al., 2013). The study’s population was 109,046 women 
and 47,684 men. The study found that there is an evidence indicating that the risk of 
colorectal pathogenesis and carcinogenesis increases exponentially around age 50 
(Morikawa et al., 2013).  
2.2.2 Sex 
Literature and studies showed that sex plays a role in the risk of CRC. Most studies showed 
that men are at more risk than women. Table 2.2 shows the literature that studied the 
association between sex and CRC risk. 
A case control study in Bavaria to assess the Risk of advanced colorectal neoplasia 
according to age and gender found that the risk is higher in men than women. It was with 
an odds ratio of 1.95; 95% confidence interval, CI, 1.91 to 2.00).(Kolligs et al., 2011).  
A retrospective cohort study was conducted at the US in 1993 to determine the Colonic 
neoplasia in asymptomatic persons with negative fecal occult blood test (Rex et al., 1993). 
The study used 310 men and 186 women and it concluded that the prevalence of colonic 
neoplasia in asymptomatic persons with negative fecal occult blood tests is substantial, 
particularly in elderly males (Rex et al., 1993) 
In Spain a prospective cohort study that aimed to build a predictive model based on a few 
simple variables that could be used as a guide for identifying average risk adults more 
suitable for examination with colonoscopy as a primary screening test.  
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The study’s population was 1649 men and 561 women. The study found that gender affects 
the risk of CRC and used gender as a major variable alongside BMI and age to build its 
predictive model (Betes et al., 2003). 
A cross sectional study in Poland in 2006 that aimed to derive and validate a model for the 
detection of advanced neoplasia in the large bowel during screening colonoscopy and to 
determine the number of persons who would have to undergo colorectal-cancer screening 
in order to detect one advanced neoplasia in various age groups and to compare these 
numbers in men and women. Results showed that  male sex was independently associated 
with advanced neoplasia (adjusted odds ratio, 1.73; 95% confidence interval, 1.52 to 1.98; 
P<0.001) (Regula et al., 2006). 
2.3 Lifestyle Factors 
Lifestyle factors are of a great concern in our study, since some of them are considered risk 
factors, while the others are considered protective factors. In our study we are going to 
address the major lifestyle factors of smoking, alcohol consumption, physical activity and 
Diet. 
2.3.1 Smoking 
Smoking was shown to be a risk for CRC. Table 2.3 shows the literature that studied the 
association between smoking and CRC risk. 
In two prospective cohort studies one was conducted in USA (Hannan, Jacobs, & Thun, 
2009) and the other was conducted in Norway (Parajuli et al., 2014). Both aimed to 
determine the relationship between CRC and smoking. Both studies found out that smoking 
increases the risk of CRC. 
A case control study was conducted in Newfoundland and Labrador that its objective was 
to examine if CRC is associated with smoking in NL population. The study used 702 cases 
and 717 control and resulted that cigarette smoking increased the risk of CRC in the NL 
population.  Current and former smokers OR  1.36 CI= 1.04 - 1.77 and 1.96 CI= 1.40 - 
2.76 (Zhao et al., 2010).  
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Another case control study in Germany that aimed to assess the risk of CRC associated 
with lifetime cigarette smoking and the effect of smoking cessation, taking into account 
relevant potential confounders and also to investigate possible effect modification. The 
study found smoking for a long duration at a high cumulative dose increases the risk for 
colorectal cancer > 40 pack-years of smoking (OR: 1.92, 95% CI: 1.13–3.28) (Verla-Tebit, 
Lilla, Hoffmeister, Brenner, & Chang-Claude, 2006). 
2.3.2 Alcohol consumption 
Many studies resulted that alcohol consumption is a risk factor for colorectal cancer. Table 
2.4 shows the literature that studied the association between alcohol consumption and CRC 
risk. 
A case control study in China that evaluated the association between CRC and alcohol 
consumption resulted in that Alcohol consumption was associated with increased 
colorectal cancer risk, but OR was significant only among heavy drinkers (OR=2.18, for 
≥21 drinks/week) (Wang, Yang, Shen, Ge, & Lin, 2017). 
A prospective follow up study that investigated whether the association between alcohol 
consumption and colon cancer risk differed by family history of colorectal cancer in USA. 
The study followed 87,861 women for 26 years and 47,290 men for 20 years and it 
concluded that reducing alcohol consumption may decrease the incidence of colon cancer, 
especially among those with a family history of colorectal cancer. The study concluded 
that reducing alcohol consumption may decrease the incidence of colon cancer, especially 
among those with a family his- tory of colorectal cancer (Cho, Lee, Rimm, Fuchs, & 
Giovannucci, 2012). 
A population based case control study in Denmark that aimed to investigate the relationship 
between amount and type of alcohol and the risk of colon and rectal cancer found that 
alcohol intake is associated with a significantly increased risk of CRC (Pedersen, Johansen, 
& Grønbaek, 2003). 
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2.3.3 Physical Activity 
Studies suggest that physical activity plays a protective role against the risk of CRC. Table 
2.5 shows the literature that studied the association between physical activity and CRC 
risk. 
A population-based cohort study in Norway that consisted of 53,242 males and 28,274 
females that aimed to examine the association between self-reported occupational and 
recreational physical activity and the subsequent risk of colorectal cancer. The study found 
that there is a protective effect of physical activity on colon cancer risk with regard to 
energy balance, dietary factors, age, social class, body mass index and gastrointestinal 
transit time (Thune & Lund, 1996). 
A population-based study of 952 cases of CRC and 1,205 of controls was conducted in 
Utah and northern California between 1997 and 2002. The study authors evaluated the 
association between physical activity and rectal cancer and the study concluded that 
physical activity was associated with reduced risk of CRC (Slattery et al., 2003) 
A case control study in Iran that also resulted in that the risk of CRC will decrease in 
individuals with higher leisure physical activities (OR = 0.82, CI 95%: 0.73–
0.98) (Golshiri, Rasooli, Emami, & Najimi, 2016).  
A cohort prospective study in the USA that aimed to assess the relationship between the 
risk of CRC, its mortality and incidence, and physical activity concluded that regular long 
term physical activity was associated with a lower risk of colon cancer mortality (Wolin et 
al., 2010). 
2.3.4 Diet 
Many dietary factors were found to be a risk factor for colorectal cancer. For example, 
many studies suggested that high intake of red and processed meat is associated with 
significant increased risk of colorectal cancer. Table 2.6 shows the literature that studied 
the association between diet and CRC risk. 
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Three cohort prospective studies in Japan, USA, and Europe (Ribeka et al,2011, Chao et 
al, 2005, Norat et al 2005), as well two case control studies in KSA (Nashar et al, 2008) 
and Canada (Chen et al, 2015) all suggested that red and processed meat are risk factors 
for CRC.  Other dietary factors were found to be protective against CRC. In a prospective 
cohort study in Sweden (Terry et al 2001) it was found that fruits and vegetables are 
protective against CRC.  
In another prospective cohort study conducted in 10 European countries (Murphy et al 
2012) they found out that fibers are protective against CRC. Nashar et al case control study 
in KSA showed similar results in the protection against CRC with the intake of fruits, 
vegetables, and fibers and Chen et al case control study in Canada also showed that plant-
based diet is protective against CRC. (See table 1 for more details) 
2.4 Family History 
Studies found that a family history of colorectal cancer increases colorectal cancer risk. 
Table 2.7 shows the literature that studied the association between family history and CRC 
risk. 
A prospective cohort study in the US conducted between 1986 and 2004 consisted of 
51,529 male US health professionals  that aimed to assess the association between family 
history and CRC risk found that the number of adenomas was positively associated with a 
family history of colorectal cancer (Wark, Wu, van ’t Veer, Fuchs, & Giovannucci, 2009).  
Another cohort prospective study was conducted in USA in 2009 that followed 75,999 
participants to evaluate the relationship between Family history of prostate and colorectal 
cancer and risk of colorectal cancer in the Women’s health initiative. The study concluded 
that the risk of colorectal cancer is increased similarly among women with colorectal 
cancer only and among those with both colorectal and prostate cancer diagnosed among 
first-degree family members (Beebe-Dimmer et al., 2017). 
A case control study in Iran that aimed to define the colorectal cancer risk associated with 
a family history of cancer. The study found that a family history of cancer increases the 
risk of CRC by two folds (Moghimi-Dehkordi et al., 2010).  
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Another case control by (Kotake, Koyama, Nasu, Fukutomi, & Yamaguchi, 1995) was 
conducted in Japan in 1994. The objective of the study was to investigate the relation of a 
family history of cancer and environmental factors to colorectal cancer. The study findings 
suggest that a family history of colorectal cancer is an important risk factor for this disease 
(Colon: OR= 2.0, 95% (CI) 1.03-3.87)),( rectal : (OR = 2.1 CI 0.94-4.48))(Kotake et al., 
1995). 
In Italy another case control study was conducted. The study aimed to investigate the 
family history of cancer and the risk of CRC. This study confirms that a family history of 
CRC in first-degree relatives increases the risk of both colon and rectal cancer, the 
association being stronger at younger ages and for right colon (Negri et al., 1998). 
2.5 Personal History of Polyps 
According to Mayo Clinic, polyps are a small clump of cells that forms on the lining of the 
colon. Most colon polyps are harmless. But over time, some colon polyps can develop into 
colon cancer (Mayo Clinic, 2018). 
Coleman et al conducted a prospective cohort study on 6,972 adenoma patients to quantify 
CRC risk following polypectomy in a large prospective population-based cohort study. The 
study findings suggest that CRC risk was elevated in individuals following polypectomy 
for adenoma (Coleman et al., 2015).  
2.6 Consanguinity 
There is no evidence that consanguinity is a risk for CRC. Many epidemiological studies 
indicated that consanguinity has very low or no effect on the risk of developing cancers 
such as the study of Bener in 2006. Very little studies discussed consanguinity and CRC.  
A case control study in Qatar aimed to examine whether parental consanguinity affects the 
risk of cancer in a local Arab highly inbred population. The study included 370 cases and 
635 controls.   
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The results were that consanguinity has no effect on the overall cancers incidence. It also 
found that there was an increased risk found for leukemia and lymphoma, colorectal and 
prostate cancer groups, but a reduced risk in breast, skin, thyroid and female genital cancer 
groups (Bener et al., 2006.). 
2.7 Medications and supplements 
Many medications and supplements decrease the risk of CRC and act as a preventive 
against the disease while some other may increase the risk. Table 2.8 shows the literature 
that studied the association between medications and supplements and CRC risk. 
A nested case control study in the UK that aimed to investigate the risk of CRC among 
new-users of low-dose aspirin (75–300 mg), including risk by stage at diagnosis. The study 
used two cohort each contain 170,336 participants. The study indicated that the patients 
who are starting a low dose of aspirin therapy have a reduced risk of Stages B–D CRC 
(García Rodríguez, Soriano-Gabarró, Bromley, Lanas, & Cea Soriano, 2017).  
A meta-analysis study of prospective cohort studies that addressed the relationship between 
dietary supplement use and the risk of colorectal cancer. The study concluded that the 
studies suggest that there is  a beneficial role for multivitamins and calcium supplements 
on colorectal cancer risk, while the association with other supplements and colorectal 
cancer risk is inconsistent (Heine-Bröring et al., 2015).   
A case control study of 289 cases and 314 controls in USA between 1994 and 1996 
indicated that there is an  inverse association of serum 25-(OH)D with colorectal adenoma 
is suggested to be stronger in subjects with calcium intake above the (Peters et al., 2001).  
A randomized trail study for 39,876 female US health professionals to evaluated 
associations between intakes of folate and vitamin B6 and colorectal cancer risk in women 
enrolled in a randomized trial of aspirin and vitamin E. The findings suggest that there is 
an inverse association between folate intake and the risk of colorectal cancer (Zhang et al., 
2006).  
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Another randomized trial study to examine the association between NSAID use and CRC 
mortality among 160,143 post-menopausal women enrolled in the Women's Health 
Initiative. The study results suggest that NSAID use is associated with lower CRC 
mortality and risk among post-menopausal women who use these medications more 
consistently over time (Coghill et al., 2012).  
A randomized trial study to assess the effect of folic acid supplementation on recurrent 
colorectal adenoma. The study randomly assigned participants to receive folic acid (1 
mg/d) (n = 338) or placebo (n = 334) for 3–6.5 y. The study findings do not support an 
overall protective effect of folic acid supplementation on adenoma recurrence (Wu et al., 
2009). 
2.8 Health Status 
The health status of the people plays a key role in their risk of having CRC. Diabetes, BMI 
and dyslipidemia all affect the risk of CRC. Table 2.9 shows the literature that studied the 
association between health status and CRC risk. 
A prospective cohort study in USA on 599 diabetic and 17,681 nondiabetic adults to 
quantify the association of treated diabetes with cancer incidence and cancer mortality. The 
study concluded that diabetes appears to exert a greater influence downstream on the risk 
of mortality in people with cancer than on upstream risk of incident cancer (Yeh et al., 
2012). 
Another prospective cohort study to assess the influence of pre-existing diabetes on 
prognosis of patients with colorectal cancer on 1,213 patients aged 67 or older with 
colorectal cancer. The study results suggest that pre-existing diabetes increased risk of total 
mortality among patients with colorectal cancer, especially among cancer patients who had 
diabetes with complications (Luo, Lin, He, & Hendryx, 2014). 
In Japan another prospective cohort study was conducted to estimate whether diabetes 
mellitus (DM) may be associated with an increased risk of colorectal cancer (CRC) 
mortality. The study used 40,510 men and 55,571 women and concluded that the risk of 
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CRC mortality is significantly increased in both sexes and women with diabetes (Tan et 
al., 2016).  
A prospective cohort study to assess if BMI is a risk for CRC or not. The study was on 
46,551 participants 50-80 years old and colon cancer mortality was assessed after 30 years 
of follow-up. The study confirms that there is a relationship between BMI and long-term 
colorectal cancer mortality. Modulation of BMI may reduce risk of CRC mortality 
(Shaukat, Dostal, Menk, & Church, 2017). 
A retrospective cohort study on 1.79 million Israeli men and women to examine the 
association between the body mass index (BMI) in late adolescence and the risk of colon 
and rectal cancer. The study found that being overweight or obese in adolescence was 
associated with an increased risk of subsequent colon cancers in men and women, whereas 
obesity was associated with rectal cancer (Levi et al., 2017).  
A nest case cohort study on 34,148 subjects in Italy to examine the relationship between 
CRC risk and dyslipidemia. The study  findings suggest that high levels of total and LDL 
cholesterol increase colorectal cancer risk, particularly in men and postmenopausal women 
(Agnoli et al., 2014).  
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Table 2.1: Studies on association between Age and CRC risk 
 
  
Conclusion Sample Size Study design Location and date Authors 
A simultaneous increase in the 
rate of radical resection among 
elderly patients, reflecting more 
effective treatment, may underlie 
this finding. 
All patients over 75 
years old from 1977 to 
1999 
Population based Study Denmark 1977-1999 Iversen et al 2005 
In an equal-access system, young 
age at presentation (<50 years) 
was associated with advanced 
stage and higher recurrence of 
colorectal cancer, but similar 
survival in comparison with older 
patients.  
7948 patients retrospective large multi-
institutional database 
analysis. 
USA 1993- 2008 Steele et al 2014 
The frequency of right-sided 
colon cancer increases with 
patient age. 
2942 consecutive 
patients (1907 men, 
1035 women; mean age 
61 years, range 11 to 95 
years) 
Prospective cohort study Japan 1995-1998 Okamoto et al 2002 
evidence indicating that the risk 
of colorectal pathogenesis and 
carcinogenesis increases 
exponentially around age 50 
109,046 women and 
47,684 men  
Prospective cohort study USA, Boston 2012 Morikawa et al 2013 
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Table 2.2: Studies on association between Gender and CRC Risk 
 
 
 
  
Conclusion Sample Size Study design Location and 
date 
Authors 
Men are at higher risk of having  
advanced neoplasia diagnosed upon  
colonoscopy than women. 
625,918 outpatient Case control Bavaria 2006-
2008 
(Kolligs et al., 
2011) 
The prevalence of colonic neoplasia in  
asymptomatic persons with negative fecal occult 
blood tests is substantial, particularly in elderly males. 
310 males and 186 females Retrospective 
study 
USA 1993 (Rex et al., 1993) 
Gender increases the risk of CRC. Males are more at risk. 
Age, gender, and BMI can be used to build a simple  
score to select those average risk adults who might be 
 candidates for primary screening colonoscopy. 
1649 males and 261 
females 
Prospective Study Spain 2003 (Betes et al., 
2003) 
The study detected advanced neoplasia at a significantly  
higher rate in men than in women, which may 
 warrant refinement of the screening recommendations for 
colorectal cancer. 
18012 males and 32136 
females 
Cross sectional 
study 
Poland 2006 (Regula et al., 
2006) 
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Table 2.3: Studies on association between Smoking and CRC Risk 
Conclusion Sample Size Study design Location and date Authors 
The study confirmed that 
heavy alcohol consumption 
was associated with an 
increasing risk of colorectal 
cancer 
310 cases 620 controls Case control China 2008-2013 (Wang et al., 2017) 
Reducing alcohol 
consumption may decrease 
the incidence of colon cancer 
87,861 women 
and 47,290 men  
 
Prospective cohort USA 1980-1986 (Cho et al., 2012) 
Alcohol intake is associated 
with a significantly increased 
risk of CRC 
15 491 men and 13 641 
women, 
Prospective cohort Denmark 2002 (Pedersen et al., 2003) 
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Table 2.4: Studies on the association between Alcohol consumption and CRC Risk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion Sample Size Study design Location and date Authors 
The study confirmed that heavy  
alcohol consumption was  
associated with an increasing  
risk of colorectal cancer 
310 cases 620 controls Case control China 2008-2013 (Wang et al., 2017) 
Reducing alcohol consumption 
 may decrease the incidence of colon cancer 
87,861 women 
and 47,290 men  
 
Prospective cohort USA 1980-1986 (Cho et al., 2012) 
Alcohol intake is associated with 
 a significantly increased risk of CRC 
15 491 men and 13 641 women, Prospective cohort Denmark 2002 (Pedersen et al., 2003) 
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Authors Location and date Study Design Sample size Conclusion 
(Thune & Lund, 
1996) 
Norway 1972-1978 Cohort prospective 53,242 males and 28,274 
females 
protective effect of physical activity on colon 
cancer  
(Slattery et al., 2003) Utah and northern 
California 1997-2002 
Case control 952 cases and 1205 controls physical activity was associated with reduced 
risk of rectal cancer in these data. The 
reduced risk was similar to that previously 
observed for colon cancer. 
(Golshiri et al., 
2016) 
Iran 2006-2008 Case Control 100 cases and 400 controls that the risk of CRC will decrease in 
individuals with higher leisure physical 
activities 
(Wolin et al., 2010) USA 1982- 1997 and 
1998-2005 
Cohort Prospective Ten-year physical activity 
analysis included 1,863 
incident and 826 fatal cases, 
whereas the longer-term 
exposure analysis included 
1,386 incident and 602 fatal 
colon cancer cases. 
Regular long-term physical activity was 
associated with a lower risk of colon cancer 
mortality. 
Table 2.5: Studies on association between Physical Activity and CRC risk. 
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Table 2.6: Literature on Association between Diet and CRC risk. 
 
 
Authors Study 
Design 
Location 
and date 
Analysis 
Methods 
objectives Sample 
size 
Protective factors Risk factors   Conclusion 
Ribeka 
et al 
2011  
Prospective 
cohort 
Japan 
1995-1998 
Cox 
proportional 
hazards 
model 
To examine 
associations between 
the consumption of red 
and processed meat and 
the risk of subsite-
specific colorectal 
cancer by gender in a 
large Japanese cohort.  
80,658 
men and 
women 
aged 45-74 
years 
non Red meat  
Women : HR= 
1.48 (1.01, 
2.17; trend 
p=0.03) 
Men : HR=1.44 
(1.06, 1.98; 
trend p=0.07 
red meat intake may 
modestly increase the 
risk of colon cancer 
in middle-aged 
Japanese, although 
the highest quintile of 
red meat consumption 
could be considered 
moderate by Western 
standards. 
Chao et 
al 2005 
Prospective 
cohort 
US 1982-
1992/1993 
Cox 
proportional 
hazards 
model 
To examine the 
relationship between 
recent and long-term 
meat consumption and 
the risk of incident 
colon and rectal cancer 
 148 610 
adults aged 
50 to 74 
years 
non processed meat 
(RR, 1.50; 95% 
[CI], 1.04-
2.17), 
Red Meat : RR, 
1.71; 95% CI, 
1.15-
2.52; P = .007 
for trend 
 prolonged high 
consumption of red 
and processed meat 
may increase the risk 
of cancer in the distal 
portion of the large 
intestine 
Norat et 
al 2005 
Prospective 
cohort 
Europe (10 
countries) 
1992-1998 
Cox 
proportional 
hazards 
model 
To examine whether 
associations exist 
between intakes of red 
and processed meat, of 
poultry, and of fish and 
colorectal cancer risk 
478 040 
men and 
women 
from 
 fish (>80 g/day 
versus <10 g/day, 
HR = 0.69, 95 % 
CI = 0.54 to 
0.88; Ptrend<.001) 
 red and 
processed meat 
(highest [>160 
g/day] versus 
lowest [<20 
g/day] intake, 
HR = 1.35, 
95% CI = 0.96 
to 
1.88; Ptrend=.03) 
Our data confirm that 
colorectal cancer risk 
is positively 
associated with high 
consumption of red 
and processed meat 
and support an 
inverse association 
with fish intake. 
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Authors Study 
Design 
Location 
and date 
Analysis 
Methods 
objectives Sample 
size 
Protective factors Risk factors   Conclusion 
Nashar 
et al 
2008 
Case 
Control  
KSA  odds ratio 
(OR) 
to assess various dietary 
factors and the 
nutritional status of 
hospitalized patients 
with colorectal cancer. 
50:50 Beef (OR=0.18, 
p<0.02) 
Bran  (OR=0.04, 
p<0.01) 
breakfast cereals 
(OR=0.11, 
p<0.01), broccoli 
(OR=0.12, 
p<0.02), cabbage 
(OR=0.21, 
p<0.04), banana 
(OR=0.2, p<0.01), 
and grapes 
(OR=0.23, 
p<0.01) 
lamb 
(OR=13.5, 
p<0.01) 
chicken with 
the skin and 
fried eggs 
(OR=4, 
p<0.01) and 
(OR=4.93, 
p<0.01) 
milk (OR=9.88, 
p< 0.04) and 
(OR=10.5, 
p<0.03) 
The higher 
consumption of 
meat and fat from 
animal sources 
could increase the 
risk of colorectal 
cancer. The high 
consumption of 
whole wheat bread, 
fruits and 
vegetables with 
high fiber content 
could play a 
protective role 
against the risk of 
colorectal cancer in 
the Saudi society.  
Terry et 
al 2001 
Prospective 
cohort 
Sweden 
1998 
Cox 
proportional 
hazards 
model 
To investigate the 
protective effect of 
fruit, vegetable, and 
dietary fiber 
consumption on 
colorectal 
cancer risk. 
61 463 
women 
High consumption 
of fruits and 
vegetables  
non Individuals who 
consume very low 
amounts of fruit 
and vegetables 
have the greatest 
risk of 
colorectal cancer. 
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Authors Study 
Design 
Location 
and date 
Analysis 
Methods 
objectives Sample 
size 
Protective factors Risk factors   Conclusion 
Murphy 
et al 
2012 
Prospective 
cohort 
Europe 10 
countries  
Cox 
proportional 
hazards 
model 
To estimate the 
association by cancer 
sub-site and fiber food 
source; and to 
scrutinize the fiber-
colorectal cancer 
relationship further by 
examining possible 
interactions by age, sex, 
and other lifestyle, 
anthropometric, and 
dietary variables. 
521,448 
participants 
fiber 0.87, 95% 
CI: 0.79–0.96 
non Our results 
strengthen the 
evidence for the 
role of high dietary 
fibre intake in 
colorectal cancer 
prevention. 
 
 
 
 
 
 
 
 
Chen et 
al.2015 
Case 
Control 
Canada 
2015 
Conditional 
and 
unconditional 
logistic 
models  
to assess if dietary 
patterns are 
associated with the risk 
of CRC in the 
population of 
Newfoundland and 
Labrador (NL) 
506 
CRC 
patients 
(306 men 
and 200 
women) 
and 673 
controls 
(400 men 
and 273 
women) 
plant-based diet 
OR of 0.55 
(95% CI: 0.35-
0.87) 
Meat-diet 
(ORs) of 1.84 
(95% CI: 1.19-
2.86) 
Sugary-diet OR 
2.26 (95% CI: 
1.39-3.66) 
 
Meat-diet/Sugary-
diet patterns 
increased and 
Plant-based diet 
pattern decreased 
the risk 
of CRC 
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Authors Location and date Study Design Sample size Conclusion 
(Wark et al., 2009) USA 1984-2004 Prospective cohort 51,529 males Adenomas was also positively associated 
with a family history of colorectal cancer.  
(Beebe-Dimmer et al., 
2017) 
USA 2009 Prospective cohort 75,999 participants Findings suggest risk of colorectal cancer is 
increased similarly among women with 
colorectal cancer only and among those with 
both colorectal and prostate cancer diagnosed 
among first-degree family members.  
 
  
(Moghimi-Dehkordi et 
al., 2010) 
Iran 2010 Case control 393 patients (231 
males and 162 
females) and 393 
controls 
A family history of cancer increases the risk 
of CRC by two folds 
(Kotake et al., 1995) Japan 1992-1994 Case Control 363 case and 363 
controls 
Our findings suggest that a family history 
of colorectal cancer is an important risk 
factor for this disease 
(Negri et al., 1998) Italy 1998 Case Control 1225 incident cases of 
colon cancer, 728 
cases of rectal cancer 
and 4154 controls 
This study confirms that a family history of 
CRC in first-degree relatives increases the 
risk of both colon and rectal cancer, the 
association being stronger at younger ages 
and for right colon. 
Table 2.7:  Literature on Association between Family history and CRC risk 
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Authors Location and date Study Design Sample size Conclusion 
(García Rodríguez et 
al., 2017) 
UK 2000 - 2009 Nested Case Control  Two cohorts each 
170,336 
Patients starting low-dose aspirin therapy 
have a reduced risk of Stages B–D CRC, 
suggesting a role for low-dose aspirin in the 
progression of established CRC 
(Peters et al., 2001) USA 1994-1996 Case Control 289 cases and 314 
controls 
There is an inverse association of serum 25-
(OH)D with colorectal adenoma is suggested 
to be stronger in subjects with calcium intake 
above the median (P for multiplicative 
interaction 0.13).  
(Zhang et al., 2006) USA 1992 Randomized Trial 39,876 female US 
health professionals 
Findings suggest an inverse association 
between folate intake and the risk of 
colorectal cancer,  
(Coghill et al., 2012) USA 1993-1998 Randomized Trial  161,808 post-
menopausal women 
The results support prolonged NSAID use in 
post-menopausal women for the prevention of 
poor CRC outcomes. 
(Wu et al., 2009) USA 1996 - 2004 Randomized Trial 338 subjects and 334 
placebos 
The study results do not support an overall 
protective effect of folic acid supplementation 
on adenoma recurrence.  
Table 2.8: Literature on association between Medications and supplements and CRC risk 
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Table 2.9:  Literature on association between health status and CRC risk 
Authors Location and date Study Design Sample size Conclusion 
(Yeh et al., 2012) USA 1989-2006 Prospective cohort  599 diabetic and 
17,681 nondiabetic 
adults 
Diabetes appears to exert a greater influence 
downstream on the risk of mortality in people 
with cancer than on upstream risk of incident 
cancer. 
(Luo et al., 2014) USA 2009-2012 Prospective cohort 61,213 patients Pre-existing diabetes increased risk of total 
mortality among patients with colorectal 
cancer, especially among cancer patients who 
had diabetes with complications.  
(Tan et al., 2016) Japan 2009 Prospective cohort 40,510 men and 
55,571 women 
The risk of CRC mortality is significantly 
increased in both sexes and women with 
diabetes. 
(Shaukat et al., 2017) USA 2007 Prospective cohort 46,551 participants Modulation of BMI may reduce risk of CRC 
mortality. 
(Levi et al., 2017) Israel 2012 Retrospective cohort  1,087,358 Jewish 
men and 707,212 
Jewish women  
Being overweight or obese in adolescence 
was associated with an increased risk of 
subsequent colon cancers in men and women, 
whereas obesity was associated with rectal 
cancer. 
(Agnoli et al., 2014) Italy 2014 Nested case cohort study 34,148 subjects The findings suggest that high levels of total 
and LDL cholesterol increase colorectal 
cancer risk, particularly in men and 
postmenopausal women.  
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Chapter Three: Conceptual Framework 
3.1 Introduction 
This chapter links the factors that are associated with the incidence of colorectal cancer 
(i.e. the conceptual framework components). These factors are divided into two main 
groups: Non-modifiable risk factors such as age, gender family history and hereditary 
factors, and modifiable factors i.e. environmental and lifestyle factors that may play an 
important role in the incidence and development of colorectal cancer(Haggar & Boushey, 
2009).  
In literature personal history of adenomatous polyps, personal history of inflammatory 
bowel disease, family history, and inherited genetic factors were shown as non-modifiable 
risk factors that are associated with the occurrence of CRC (Aicr& WCRF, 2007; American 
Cancer Society, 2018; Haggar & Boushey, 2009; Janout & Kollárová, 2001; Mayoclinic, 
2018; National Institutes of Health, 2006). On the other hand, diet, physical activity, 
obesity, cigarette smoking and alcohol consumption were shown as factors associated with 
CRC but are considered modifiable factors for CRC(Aicr& WCRF, 2007; American 
Cancer Society, 2018; Haggar & Boushey, 2009; Janout & Kollárová, 2001; Mayoclinic, 
2018; National Institutes of Health, 2006).  
 
3.2 Colorectal cancer definition 
Colorectal cancer is a development of tumor from the colon or rectum. It may be benign, 
or malignant(American Cancer Society, 2018). It is also called bowel cancer. Most 
colorectal cancer cases are because of old age and lifestyle factors, and some of the cases 
are due to some genetic disorders (Aicr & WCRF, 2007).  
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3.3 Colorectal cancer diagnosis 
Colorectal cancer may be diagnosed using tests and procedures in which the doctors need 
to examine the malignant cells. Diagnosis aims to take samples from areas of the colon that 
are suspicious for tumor development. Samples are taken during colonoscopy or 
sigmoidoscopy, and that depends on the location of the tumor. Then the sample are 
confirmed by microscopic examination of the taken sample (Cunningham et al., 2010). 
The most common screening and diagnosis procedures and tests are: Fecal occult blood, 
colonoscopy, sigmoidoscopy, CT scan, and blood tests.  
 
3.4 Theoretical and Conceptual framework 
According to literature review and after reviewing all models suggested for risk factors 
for colon and rectum cancers, the theoretical models in the world summary i.e. American 
Cancer Society, Mayo Clinic indicates the following:  
The risk factors are summarized as follows: 
- Socio-demographic factors (e.g. age, sex, and race\ethnicity). 
- Life style factors (e.g. diet type, smoking, physical activity and alcohol 
consumption). 
-  Family history (e.g. having a close relative with colorectal cancer). 
- Medical conditions (e.g. diabetes mellitus)  
- Medication (e.g. aspirin). 
- A personal history of inflammatory bowel disease 
- A personal history of colorectal polyps or colorectal cancer 
- Inherited syndromes (e.g. familial adenomatous polyposis (FAP) and Lynch 
syndrome (hereditary non-polyposis colorectal cancer, or HNPCC) 
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Conceptual framework for this study: 
 
• Socio-demographic factors (e.g. age, sex, and race\ethnicity). 
• Life style factors (e.g. diet type, smoking, physical activity and alcohol 
consumption). 
• Family history (e.g. having a close relative with colorectal cancer). 
•  Medical conditions (e.g. diabetes mellitus)  
•  Medication (e.g. aspirin, ibrufen, and supplements). 
• A personal history of inflammatory bowel disease 
• A personal history of colorectal polyps or colorectal cancer 
•  Consanguinity marriage that is popular in the Palestinian community. 
 
 
 
Figure 2: Study Conceptual Framework 
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3.5 Colorectal Cancer and socio-demographic risk factors 
3.5.1 Age 
Colorectal cancer diagnosis increases with age. It increases progressively from age 40, 
rising highly after the age 50 (Rise et al, 2008). 90% and more of colorectal cancer cases 
occur in people of age 50 and older (Rise et al, 2008). Colorectal cancer incidence rate in 
people aged 60 to 79 years is more than 50 times higher than people younger than 40 years 
(ACS, 2009). However, colorectal cancer is increasing among younger people (O’Connell 
et al, 2003). 
3.5.2 Sex 
Risk of colorectal cancer (CRC) is considerably higher in men compared to women (Majek 
et al, 2013).  
3.6 Colorectal cancer and lifestyle factors 
3.6.1 Smoking 
Smoking is harmful to the colon and rectum. It is estimated that about 12% of colorectal 
cancer deaths are attributed to smoking (Zisman et al, 2006). Evidence shows that the 
carcinogens that are found in the tobacco increases cancer growth in the colon and rectum, 
and thus increases the risk of colorectal cancer diagnosis (Janout et al, 2001). Cigarette 
smoking is crucial for the formation and growth rate of adenomatous polyps, the colorectal 
cancer precursor lesions. Larger colon polyps were found in the colon and rectum of long-
term smokers (Botteri et al, 2008).   
3.6.2 Alcohol consumption 
Alcohol consumption is associated with increased risk of developing colorectal cancer. 
Alcohol consumption plays a key factor in the diagnosis of colorectal cancer at a younger 
age (Zisman et al, 2006).  Also alcohol consumption increases the proportion of tumors in 
the colon (Bazensky et al, 2007). The mechanism is believed to be that the reactive 
metabolites of alcohol such as acetaldehyde are carcinogenic (Pöschl et al, 2004).  
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Alcohol may also serve as a solvent, that enhances the penetration of other carcinogenic 
molecules into mucosal cells (Pöschl et al, 2004). It is also believed that alcohol high 
consumers may have diets that are low in the essential nutrients, that leads to make the 
tissues more susceptible to carcinogenesis (Pöschl et al, 2004). 
3.6.3 Physical Activity 
Physical inactivity and overweight, are reported to be responsible for about about fourth to 
third of colorectal cancer cases (Boyle et al 2000). It has been proven that higher levels of 
physical activity are associated with a lower risk of developing colorectal cancer. The 
relationship is believed to be a dose–response relationship, with the increase of frequency 
and intensity of physical activity it will inversely lower the risk of developing colorectal 
cancer (Boyle et al 2000, Lee KJ et al, 2007). Maintaining regular levels physical activity 
in addition to a healthy diet will decrease the risk of colorectal cancer. The mechanism of 
the relationship between physical activity and colorectal cancer risk that the physical 
activity raises the metabolic rate and increases oxygen uptake (Lee KJ et al, 2007). It also 
increases the body's metabolic efficiency and capacity, and reduces blood pressure and 
insulin resistance. In addition to all of that, physical activity increases gut motility thus 
reducing colorectal cancer risk (Lee KJ et al, 2007). 
3.6.4 Diet  
There’s a strong association between diet and the risk of colorectal cancer. It is believed 
that changes in food habits may reduce up to 70% of colorectal cancer burden (Willett, 
2005). High fat diets, especially from animal origin, are considered to be a major risk factor 
for colorectal cancer (Boyle et al, 2000). High meat consumption has also been associated 
with increased risk of developing colorectal cancer (Larsson et al, 2006). The mechanisms 
for this association between red meat consumption and colorectal cancer is believed to be 
due to that red meat include the presence of heme iron (Kabat et al, 2007). Also cooking 
meats at high temperatures, results in the production and release of free radicals such as 
heterocyclic amines and polycyclic aromatic hydrocarbons, that are believed to be 
carcinogenic (Santarelli et al, 2008). Some studies suggest that people who consume low 
in fruits and vegetables diets, are at higher risk of colorectal cancer (Boyle et al, 2000). 
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3.7 Family History of colorectal cancer or colon polyps 
About 20% of people who develop colorectal cancer have other family members who have 
been diagnosed or affected by colorectal cancer (Skibber et al, 2001). People who have one 
or more first-degree relatives with history of colorectal cancer or adenomatous polyps are 
at increased risk. The risk of having colorectal cancer is higher among people with a 
stronger family history, i.e.  history of colorectal cancer or adenomatous polyps in any 
first-degree relative; or history of colorectal cancer or adenomatous polyps in two or more 
first-degree relatives at any age (Boardman et al, 2007).  
3.8 Personal history of personal bowel disease 
Inflammatory bowel disease (IBD) is a term used to describe inflammation that occur in 
the colon and the small intestine. Two diseases, ulcerative colitis and Crohn disease are the 
major IBD diseases (Baumgart, 2007).  Ulcerative colitis is a long-term condition that 
results in inflammation and ulcers of the colon and rectum (NIDDK, 2014).  Crohn 
disease causes inflammation that may affect any part of the gastrointestinal 
tract from mouth to anus (NDDIC, 2013). The overall risk of developing colorectal cancer 
is increased in people who suffer from these conditions. It has been estimated that the 
relative risk of colorectal cancer in patients with inflammatory bowel disease is between 
4- to 20-fold (Janout et al, 2001).  
3.9 Personal history of colon polyps 
A colorectal polyp is clump of cells that grow on the lining of the colon. Colorectal polyps 
are harmless but if untreated and overtime can develop into colorectal cancer (Santero et 
al, 2005).  Almost 95% of colorectal cancer cases develop from colon polyps (adenomas) 
(de Jong et al, 2005). People with history of polyps (adenomas) are at increased risk of 
developing colorectal cancer, other than people who never had history of adenomas (de 
Jong et al, 2005).  
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3.10 Consanguinity 
Consanguinity is a marriage between relatives and has various degrees (Stern, 1973). There 
is a historically high prevalence of consanguineous marriages in many communities 
throughout the world, especially in countries of the Middle East, Northern Africa and South 
Asia (Al Awaadi et al, 1985).  In Palestine it has been reported that 40% of all marriages 
are consanguineous and about 20% are between first degree relatives (Freundlich et al, 
1984, Zlotogora et al, 2000).   Evidences has proven that in a population with a high rate 
of consanguinity, there is a significant increase in the prevalence of common adult diseases 
like cancer, mental disorders, heart diseases, gastro-intestinal disorders, hypertension and 
hearing deficit (Bener et al, 2007). 
3.11 Summary 
In summary, the literature showed that several risk factors associated with colorectal 
cancer, which are divided into: socio-demographic factors (e.g. age and sex), lifestyle 
factors (e.g. diet and smoking), family history (have a close relative diagnosed with 
colorectal cancer), Personal history of bowel disease (e.g. Crohn’s disease), Personal 
history of polyps, Consanguinity (Relatives marriage). These factors were used to build 
this study conceptual framework. This chapter is the base for analysis in the coming results 
chapter and the study results discussion and conclusion. 
 
 
 
 
 
 
 
 
 
  
34 
 
 
Chapter Four: Study Methodology 
In this chapter, the research methodology is presented. The study area, study population, 
study design, tools, the sampling method, statistical analysis, ethical considerations, and 
variables operational definitions are presented. 
4.1 Study setting and population characteristics 
Our study was conducted in Beit Jala Governmental hospital (BJGH). BJGH is a central 
hospital in the southern part of the West Bank. It has many vital medical specialties such 
as orthopedic, cardiovascular, ENT, surgery and oncology departments. Each medical 
specialty has an in-patient ward and out-patient clinic. All patients’ records are kept in a 
paper filled archives presented within the hospital.  
Its oncology department provides primary, secondary, and tertiary health care for cancer 
patients in the south of the West Bank. Diagnostic and therapeutic procedures are also 
presented at BJGH. These procedures include medical imaging and laboratory testing for 
diagnosis and follow-up, surgery and chemotherapy for curative and palliative entities. 
Patients could be admitted to the oncology ward to be under observation. Also, cancer 
patients are followed up in the outpatient clinics by medical oncologists(Halahleh& Gale, 
2018).  
The registered population at the cancer registry of the hospital are mainly coming from the 
middle governorates (Ramallah, Jerusalem, and Jericho) and southern governorates 
(Bethlehem and Hebron) regions of the West Bank. The registered patients from Jerusalem 
only covers those with a Palestinian Nationality not holder of Israeli ID. (see Map 1) 
Bethlehem governorate is located 10km south to Jerusalem and it has he a total area of 
around 660 km²(OCHA, 2015). 
Bethlehem governorate has a population of about 220,000 people, including over 20,000 
of them are living in three refugee camps (Dheisheh, Aida and Beit Jibrin). The most 
important cities and towns of the governorate are Bethlehem , Beit Jala, and Beit Sahour 
cities, as well Al Doha, Al Khader, Battir and Artas towns (PCBS, 2017). 
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Hebron governorate is located in the southern West Bank. It is the largest governorate in 
Palestine in terms of area and population. The governorate's land area is 1,060 square 
kilometers and it has a population of 600,364. The Hebron Governorate has a total of seven 
cities and eighteen towns(PCBS, 2017). 
Ramallah governorate covers a large part of the central West Bank. It is located on the 
north of Jerusalem Governorate.  It covers an area of 844 square kilometer and according 
to the Palestinian Central Bureau of Statistics (PCBS), the governorate has a population of 
279,730 (PCBS, 2017).  
The governorate has 78 localities which 13 of them have the status of municipality. It also 
has three refugee camps. in its jurisdiction. 13 localities have the status of 
municipality(PCBS, 2017). 
Jericho governorate is located in the eastern areas of the West Bank bordering Jordan. 
The governorate spans west to the mountains east of Ramallah and the eastern slopes 
of Jerusalem, including the northern reaches of the Judaean Desert. The population of the 
Jericho Governorate was estimated 31,501, including approximately 6,000 living in the 
governorate’s refugee camps Aqbat Jaber and Ein Al Sultan (PCBS, 2017). 
The governorate have one city which is the Jericho city, two municipalities, four villages 
and three refugee camps (PCBS, 2017).  
Jerusalem governorate is located in the central of the West Bank. The Governorate has 
two sub-districts: Jerusalem J1, which includes the localities within the territory controlled 
by the Israeli Jerusalem municipality (East Jerusalem), and Jerusalem J2, which includes 
the remaining parts of the Jerusalem Governorate. The district capital of the Governorate 
is East Jerusalem (al-Quds)(PCBS, 2017). 
The total land area of the governorate is 344 km2. According to the PCBS, the governorate 
had a population of 429,500. Palestinian ID holders account for 10.5%  (42,950) of 
Palestinians living in Jerusalem governorate(PCBS, 2017). 
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Map 1: Palestine governorates(Wikipedia, 2019) 
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4.2 Study design 
The study design is a group matched case-control study. Cases and controls were matched 
by age and gender. 
4.3 Study sample selection 
Study cases: The study cases were every colorectal cancer patient that was previously 
diagnosed and confirmed to have colorectal cancer as a primary cancer, and are attending 
to daycare clinics in BJGH for chemotherapy or consultations or were admitted in the 
oncology department. 
Cases were defined by: 
1. It should be primary CRC and confirmed by histopathology according to the 
records. 
2. Only alive patients were interviewed therefore it is a survived based study. 
3. Cases have a registry cancer file at the hospital. 
4. Patients having other cancers which we couldn’t confirm if it was primary or 
secondary cancer.  
Study control group: The controls were patients attending other hospital clinics in BJGH 
e.g. ENT clinic and internal medicine clinic or admitted in any other hospital department 
other than oncology. Those controls were invited to participate in the study. After 
consenting to participate an occult blood test was performed for these potential controls to 
exclude CRC. Controls were selected by a specific age group designed to match the cases 
and also matched the cases by gender.   
The selected controls were excluded if 
1.  Result of fecal occult was positive.   
2.  Those who refused to do the fecal occult test (FOBT).  
3.  Any patient that refuses to participate in the study. 
4. Patients who had previously diagnosed with any cancer type.  
5. Controls that completed the questionnaire who were found to have previous polyps or 
any bowel diseases were excluded in the analysis (n=3) 
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In our study 7 controls were excluded because they were FOBT positive and were referred 
for further investigation at the hospital outpatient clinic. Also, two other controls were 
excluded because they refused to perform the FOBT test. 
 
4.4 Sample size determination 
Sample size was calculated by the online software tool called “Epitool” (AUVEST, n.d.); 
for a case control study sample size determination. The following calculation parameters 
were used: an 80% power, and estimated odds ratio of 3.0 for the association between red 
meat consumption and CRC with 95% confidence as mentioned in the literature for similar 
studies carried out in Middle East (Nashar& Almurshed, 2008). Therefore, our target 
sample was about 174 (87 cases and 87 controls). However, we selected 105 cases and 105 
control group (table 3.1).  
Table 3.1: Sample size calculation Results  
 
 P = 0.005   P = 0.01   P = 0.02   P = 
0.03  
 P = 
0.04  
 P = 
0.05 * 
P = 
0.1  
OR = 2 4749 2395 1218 826 630 513 280 
OR = 3 1586 801 409 279 213 174 97 
OR = 4 882 446 228 156 120 98 56 
OR = 5 596 302 155 106 82 67 38 
OR = 10 217 110 57 39 30 25 15 
 
*the least needed sample size for our study 
4.5 Data collection 
Data collection took place in the period between May 2016 until June 2017. A field 
researcher was especially trained for the data collection. Our filed researcher was trainee 
nurse at the hospital. She was well trained to use the questionnaire, how to find the patients, 
and how to use the patient’s medical records. In that period all CRC patients visiting the 
daycare clinic were eligible to be included in the study. The data collection for the daycare 
was performed on Mondays and Wednesdays as the daycare for the cancer patients at the 
hospital work on those days. On those days the field researcher was present to do the 
survey.  
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Patients at the daycare were approached and were asked to join the study after explaining 
the study aim and objectives for them. None of those approached patients refused to 
participate in the study.   
For the admitted patients, the field researcher visited the oncology department and 
approached the admitted patients. None refused to join the study.  
Afterwards, whenever a new case was found in the daycare or admitted to the oncology 
department from the daycare, their medical records were retrieved from the registration. 
After the medical records were retrieved for each case, they were selected. At that time, 
the selected cases approval to participate was taken by signing an informed consent 
(Informed consents and approval letters are found in Appendix). Then they were 
interviewed by the field researcher. The admitted cases were interviewed at the oncology 
department. The daycare patients who came for follow up or chemotherapy were 
interviewed at the daycare. Each interview took from 20 to 30 minutes. 
For each selected case from the oncology department, a control of the same age group and 
gender was selected from other departments (Internal, surgery, and outpatient clinics).  
For cases that were selected from the daycare, a matched control who attended the 
outpatient clinics for regular consultations other than cancer was selected. Controls who 
met the study’s inclusion criteria were selected and approached by the field worker. Each 
fit control who agreed to participate in the study signed the informed consent. Then his 
medical record was retrieved and checked not be a cancer patient. After that he was 
interviewed by the field researcher after explaining the study’s aim and objectives. Two 
control refused to perform the FOBT test.  
4.6 Study tools 
4.6.1 Medical Record 
Medical records were used for both cases and controls. The records were used to confirm 
the age of the participant, to take the address, the medical record no. was saved, and were 
used to take the body measurements (Height and weight). For the cases the record was also 
used to take the age at the diagnosis for each case. 
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4.6.2 Study Questionnaire 
Most of the questionnaire questions were adopted from similar studies questionnaires that 
were previously prepared and validated, mainly they were adopted from the Risk Factor 
Questionnaire for Colorectal Cancer Family registry (CFR, 2016).  
  
The Questionnaire was modified based on the aims and objectives of the study and its 
conceptual framework. It consisted of the following parts: 
Section A: Socio-demographic data. Questions A1 to A12. 
Section B: Medical History. Questions B1 to B20h. 
Section C: Tobacco use and Alcohol. Questions C1 to D16. 
Section D: Diet. Questions E1 to E4b. 
Section E: Physical Activity. Questions P1 to P16(a-b). 
Section F: Physical Measurements. Questions G1 to G4. 
 
Questionnaire Validation 
The study questionnaire was reviewed by the study supervisor and then was sent for 
validation by 3 specialists in this field; two oncologists working at the MOH and a 
colonoscopy specialist physician. No major changes were made based on the reviewers 
comments, except for wordings in some sections to make it easier for the field researcher 
to understand and explain to the patients. Questionnaire was adjusted afterwards based on 
the given comments. Then the questionnaire was transformed into an application that is 
especially deigned to work on a tablet to make it easier to enter the data and save it. The 
application was designed by the researcher himself. 
 
Questionnaires piloting 
Questionnaire piloting was conducted at the BJGH. Twenty colorectal cancer patients were 
interviewed. The Statistical Package for Social Sciences (SPSS version 23.0) was used for 
data entry and analysis. As a result of the piloting data analysis, the questionnaire reliability 
measurement showed a Cronbach alpha of 0.81 for the separate questions sections 
mentioned above 
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4.6.3Fecal occult blood test (FOBT) 
The lab screening test used in the study was the FOBT. It is a one-step rapid test device 
which is a chromatographic immunoassay for qualitative detection of human occult blood 
in feces (Simon 1985). We have chosen the immunoassay method over the traditional guaic 
based methods, because it was proven by the literature that the immunoassay method is 
more sensitive and specific than the other methods (Simon 1985). In addition to that, other 
methods have diet restrictions prior to testing (Simon 1985).  
Stool samples were collected from the controls at the hospital. Special containers were used 
for the samples that can keep the sample from deterioration and to preserve them until they 
are tested. Then the samples were transferred to Beit Fajjar Medical Laboratory. This 
laboratory is a MOH licensed laboratory and is a certified member of the EQAS program 
(Al Quds university External assurance). The samples were tested there.  
 
4.7 Data Analysis 
The data was collected using an electronic questionnaire, then manually coded, cleaned 
and analyzed using the Statistical Package for Social Sciences (SPSS version 23.0). 
Descriptive statistics were represented to show frequencies and, percentages for categorical 
variables, means, and standard deviation for continuous variables. Chi-square test and T-
test were used as needed to calculate the difference between cases and controls regarding 
all variables in the study. A P-value <0.05 was considered statistically significant. 
Variables that showed a significant difference between cases and controls were included 
in our multivariate model for risk estimation. Conditional forward logistic regression was 
used to get odds ratios. Our principal measure of association was the Adjusted Odds Ratios 
(AORs) with 95% confidence intervals (95% CI). 
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4.8 Ethical consideration 
In order to lunch this study, this study’s proposal was submitted to Al Quds University-
School of public health research committee for discussion and approval. The permission to 
conduct the study was obtained from the MOH. All the participants were informed about 
the study aim and objectives and signed a consent form before participating.  
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Chapter Five: The Results 
5.1 Introduction 
In this chapter, study results will be presented. Study population characteristics will be 
shown in a descriptive analysis. Univariate and multivariate analysis will also be presented 
in this chapter. 
5.2 Descriptive analysis 
Our study consisted of 210 participants (105 cases and 105 controls). Table 5.10 shows the 
characteristics of the study cases. The majority of our cases were colon cancer representing 
(92.4%) and only (7.6%) were rectal cancer patients. Most of our cases (77.1%) were living 
in the southern region (Hebron and Bethlehem). The mean age of our cases was 59.5 years 
with 24 years old was the youngest case and 81 was the oldest case. Males were more than 
females in our cases representing (54.3%) of the cases. The mean years since cancer 
diagnosis in the cases was 1.8 years. Cases whom were diagnosed with polyps were 29 
which constitute of (27.6%) of the cases, and (25.7%) of the patient’s having polyps 
removed them. (2.9%) of our cases were Crohn’s positive, about (1%) of them were 
diagnosed with Ulcerative colitis, and (7.6%) of them were also diagnosed with Irritable 
bowel disease. None of our cases was diagnosed with Diverticular disease. 
Table 5.11 shows that most of our cases have undergone colon or rectum removal 
operations (93.3% of cases, and (76.2%) of them removed it completely. (14.3%) of our 
cases were treated by radiotherapy and about (2%) of cases undergone bone marrow 
transplant. Only (12.4%) of the cases had diabetes, and (2.9%) of them were diabetes 
positive before cancer. In the BMI section we notice that most of our cases were 
overweight, and most of them were obese before cancer. 
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Table 5.10: Description of study cases characteristics, disease status and treatment. 
 
Variable Count  N % 
Sex Female 48 45.7% 
Male 57 54.3% 
Age at diagnosis Mean (SD) 
 Min-Max 
59.49(11.81) 
24-81 
 
Number of years since diagnosis Mean (SD) Min-Max 1.84(1.58) 0-6 
years  
Location of cancer 
(Colon/Rectal) 
Colon 97 92.4% 
Rectal 8 7.6% 
Area of residence Southern region** 81 77.1% 
Middle region* 24 22.9% 
Polyps present No 76 72.4% 
Yes 29 27.6% 
Polyps present more than once No 0 0.0% 
Yes 29 27.6% 
I don't have polyps 76 72.4% 
Type of polyps Benign 21 20.0% 
Malignant 8 7.6% 
I don't have polyps 76 72.4% 
Removal of polyps No 2 1.9% 
Yes 27 25.7% 
No polyps 76 72.4% 
Polyps removed more than once No 13 12.4% 
Yes 16 15.2% 
No polyps 76 72.4% 
Familial Adenomatous polypsis No 102 97.1% 
Yes 3 2.9% 
Crohn's disease present No 102 97.1% 
Yes 3 2.9% 
Ulcerative colitis present No 104 99.0% 
Yes 1 1.0% 
Irritable bowel syndrome 
present 
No 97 92.4% 
Yes 8 7.6% 
*Middle region: Jerusalem, Ramallah, Jericho   ** Southern region: Hebron, Bethlehem 
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Table 5.11: Description of study cases characteristics, disease status and treatment. 
Variable Count  N % 
Remove colon or rectum No 7 6.7% 
Yes 98 93.3% 
Type of colon or rectum removal 
(Partial/Completely) 
Completely 
removed 
80 76.2% 
Partly Removed 18 17.1% 
Didn't remove 7 6.7% 
First colon or rectum remove (Years) In the past 1-2 
years 
90 85.7% 
In the past 3-6 
years 
8 7.6% 
Didn't Remove 7 6.7% 
Remove colon or rectum more than 
once 
No 35 33.3% 
Yes 64 61.0% 
Didn't remove 6 5.7% 
Diabetes No 92 87.6% 
Yes 13 12.4% 
Diabetes before cancer No 10 9.5% 
Yes 13 2.9% 
No Diabetes 92 87.6% 
Radiotherapy No 90 85.7% 
Yes 15 14.3% 
Bone marrow transplant No 103 98.1% 
Yes 2 1.9% 
BMI 18-24.9 Normal 3 2.9% 
25-29.9 
Overweight 
63 60.0% 
>30 Obesity 39 37.1% 
BMI before cancer 18-24.9 Normal 14 13.3% 
25-29.9 
Overweight 
22 21.0% 
>30 Obesity 69 65.7% 
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Univariate Analysis 
 
5.2 Socio-demographic Data 
Table 5.12 shows that our study has more males than females. It also shows that the mean 
age of our study subjects was 61 years old. No difference in marital status was observed 
between cases and controls with majority being married. Most of our cases were residents 
of cities (63.8%), whereas in controls majority were residents of villages (62.9%). In the 
education section, it was noticed that most of our controls (54.6%) were with no schooling 
while in cases (47.1%) were also with no schooling. There was no difference observed in 
the occupations section between cases and control with majority of were employed. The 
table also shows that cases have more yearly income in comparison to controls.  
Comparing study cases and control group, table 5.12 shows that there are statistically 
significant differences (P <0.05) in Residence section, yearly income and area of residence. 
Table 5.12: Socio-demographic characteristics of the study subjects 
 
Variable Study cases 
N=105 
Control Group 
N=105 
P value 
of Chi 
Square Count  N % Count  N % 
Sex Female 48 45.7% 47 44.8% 0.890 
Male 57 54.3% 58 55.2% 
Age Mean (SD)  
Min- Max 
105 61.32(12.035) 
22-89 
105 61.12(13.1021) 
22-89 
P value of 
T 
test=0.783 
Education No Schooling 48 47.1% 56 54.4% 0.545 
School (Primary and High) 44 43.1% 37 35.9% 
College and more 10 9.8% 10 9.7% 
Marital 
Status 
Single 2 1.9% 4 3.8% 0.430 
Married 93 88.6% 95 90.5% 
Divorced/Widowed/Separated 10 9.5% 6 5.7% 
Occupation Not Work 14 13.7% 18 17.6% 0.441 
Work 88 86.3% 84 82.4% 
Yearly 
Income 
(Shekels) 
Mean (SD)  
Min- Max 
105 31503(21624) 
6000-96000 
105 23178(28985) 
6000-96000 
 P value 
of T test= 
0.001 
Residence City 67 63.8% 33 31.4% <0.0001 
Village 32 30.5% 66 62.9% 
Camp 6 5.7% 6 5.7% 
Area of 
residence 
Southern region** 81 77.1% 102 97.1% <0.0001 
Middle region* 24 22.9% 3 2.9% 
*Middle region: Jerusalem, Ramallah, Jericho 
** Southern region: Hebron, Bethlehem 
47 
 
 
5.3 Medications and supplements 
Table 5.13 shows that (16.2%) of our cases take Aspirin irrespective to period and duration 
compared to (37.1%) of the control group. Comparing study cases and control group, table 
5.13 reveals statistically significant differences (P<0.05) in Aspirin, Frequency of taking 
Aspirin consumption, Taking Aspirin two years ago, and Duration of taking Aspirin. Other 
medications and supplements (Panadol, NSAIDs, Laxatives, Multivitamins, Folic Acid, 
Calcium, and Antacids) showed no significance and their tables are presented in the 
Appendix.  
Table 5.13 Association between study cases and control group by Aspirin intake 
Variable 
Study cases 
N=105 
Control group 
N=105 
P Value of 
Chi Square 
Count  N % Count  N % 
Aspirin Yes 17 16.2% 39 37.1% 0.001 
No 88 83.8% 66 62.9% 
Frequency of Taking 
Aspirin per Week* 
<7 Times 10 9.5% 25 23.8% 0.003 
≥ 7 Times 7 6.7% 14 13.3% 
Don't Take 
Aspirin 88 83.8% 66 62.9% 
Take aspirin two 
years ago 
Yes 12 11.4% 34 32.4% <0.000 
No 93 88.6% 71 67.6% 
Aspirin duration 
(Years)* 
≤ 1 Year 4 3.8% 7 6.7% 0.007 
2-5 Years 10 9.5% 26 24.8% 
≥ 6 Years 3 2.9% 6 5.7% 
Don't Take 
Aspirin 88 83.8% 66 62.9% 
*Aspirin level categorization and cut off value were according to the studies(García 
Rodríguez et al., 2017; Gray, Coleman, Hughes, Murray, & Cardwell, 2018) 
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5.4 Health Status 
Table 5.14 shows that (12.4%) of our cases have diabetes compare to (15.2%) of controls. 
About (9%) of our cases and (6.7%) of our control were diagnosed with high cholesterol 
levels. On the other hand, we have (8.6%) of our cases and (6.7%) who were diagnosed 
with high Triglycerides level. Most of our cases and controls were overweight with (60%) 
and (70.5%) respectively.  
Comparing study cases and control group, table 5.14 reveals that there are no statistically 
significant differences (P<0.05) in any of the Health status sections. 
Table 5.14:  Association between study cases and control group by Health status 
 
Variable Study Cases 
N=105 
Control Group 
N=105 
P value 
of Chi 
Square Count N % Count N % 
Diabetes present Yes 13 12.4% 16 15.2% 0.548 
No 92 87.6% 89 84.8% 
First Diabetes 
Diagnosis (Years) 
<10 years 10 9.5% 9 8.6% 0.427 
>10 years 3 2.9% 7 6.7% 
No Diabetes  92 87.6% 89 84.8% 
Take Diabetes 
medications 
Yes 13 12.4% 16 15.2% 0.548 
No diabetes 92 87.6% 89 84.8% 
Type of diabetes 
medication taken* 
Pills 7 6.7% 3 2.9% 0.121 
Insulin injections 6 5.7% 13 12.4% 
No diabetes  92 87.6% 89 84.8% 
Frequency of 
taking Diabetes 
medication per 
week 
1-7 times 8 7.6% 11 10.5% 0.770 
8-14 times 5 4.8% 5 4.8% 
No Diabetes 
92 87.6% 89 84.8% 
Take Diabetes 
medications two 
years ago 
Yes 10 9.5% 15 14.3% 0.287 
No diabetes 
95 90.5% 90 85.7% 
Overall period of 
taking diabetes 
medications 
(years) 
<5 years 7 6.7% 3 2.9% 0.121 
>5 years 6 5.7% 13 12.4% 
No Diabetes  
92 87.6% 89 84.8% 
High Cholesterol 
level  
Yes 9 8.6% 7 6.7% 0.603 
No 96 91.4% 98 93.3% 
First high 
Cholesterol 
diagnosis (years) 
<5 years 4 3.8% 3 2.9% 0.872 
>5 years 5 4.8% 4 3.8% 
No Cholesterol 96 91.4% 98 93.3% 
High Cholesterol 
medications 
Yes 9 8.6% 7 6.7% 0.603 
No cholesterol 96 91.4% 98 93.3% 
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Table 5.14…. continues 
Variables Study Cases 
N=105 
Control Group 
N=105 
P value of 
Chi Square 
count N % count N % significance 
High 
Triglycerides 
level 
Yes 9 8.6% 7 6.7% 0.580 
No 
99 94.3% 97 92.4% 
First high 
Triglycerides 
diagnosis (years) 
<5 years 3 2.9% 5 4.8% 0.771 
>5 years 3 2.9% 3 2.9% 
No Triglycerides 99 94.3% 97 92.4% 
High 
Triglycerides 
Medication 
Yes 6 5.7% 8 7.6% 0.580 
No triglycerides 
99 94.3% 97 92.4% 
BMI 18-24.9 Normal 3 2.9% 4 3.8% 0.201 
25-29.9 
Overweight 
63 60.0% 74 70.5% 
>30 Obese 39 37.1% 27 25.7% 
Remove 
gallbladder 
Yes 20 19.0% 16 15.2% 0.464 
No 85 81.0% 89 84.8% 
*none of the participants had a combined therapy for diabetes. 
 
 
5.5 Screening and Intervention 
Table 5.15 shows that about (75.2%) of our cases have performed occult blood test and all 
of them (100%) have performed colonoscopy. On the other hand, only (3.8%) of the 
controls performed the occult blood test while only (10.5%) of them have undergone 
colonoscopy. Most of the cases did the occult blood test in the past 1-2 years and the 
majority of them did it for the reason to investigate new health problem. In the colonoscopy 
section, most of the cases undergone the test in the past 1-2 years and for the reason to 
investigate new health problems. In the control group, the number of the controls who 
performed the occult blood test and undergone colonoscopy were very low in comparison 
to the cases.  
Comparing study cases and control group, table 5.15 reveals that there are statistically 
significant differences (P<0.05) in the occult blood. 
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Table 5.15: Association between study cases and control group by Screening and 
Intervention 
Variable 
Study Cases 
N=105 
Control Group 
N=105 
P Value of Chi 
Square 
Count % Count % 
Occult Blood test Yes 79 75.2% 4 3.8% <0.0001 
No 26 24.8% 101 96.2% 
First Occult blood 
test (years) 
In the past 1-2 years 70 66.7% 1 1.0% <0.0001 
In the past 3-6 years 9 8.6% 3 2.9% 
Didn't do the Test 26 24.8% 101 96.2% 
Reason for Occult 
blood test 
To investigate new 
problem 
76 72.4% 1 1.0% <0.0001 
Follow up of previous 
problem 
2 1.9% 3 2.9% 
Didn't do the test 27 25.7% 101 96.2% 
Occult Blood 
Separate Testes 
1-2 times 68 64.8% 3 2.9% ---- 
3-5 times 7 6.7% 1 1.0% 
> 6 times 4 3.8% 0 0.0% 
Didn't do the test 26 24.8% 101 96.2% 
Last occult test 
(Years) 
In the past 1-2 years 64 61.0% 2 1.9% <0.0001 
In the past 3-6 years 15 14.3% 2 1.9% 
Didn't do the Test 26 24.8% 101 96.2% 
Colonoscopy Yes 105 100.0% 11 10.5% --- 
No 0 0.0% 94 89.5% 
First Colonoscopy 
(Years) 
In the past 1-2 years 86 81.9% 6 5.7% --- 
In the Past 3-6 Years 19 18.1% 5 4.8% 
Didn't do the Test 0 0.0% 94 89.5% 
Reason for 
colonoscopy 
To investigate new 
problem 
73 69.5% 9 8.6% --- 
Follow up of previous 
problem 
32 30.5% 96 91.4% 
Didn't do the test 0 0.0% 0 0.0% 
Colonoscopy 
Separate times 
1-2 times 93 88.6% 10 9.5% --- 
3-5 times 12 11.4% 1 1.0% 
Didn't do the test 0 0.0% 94 89.5% 
Last colonoscopy 
(Years) 
In the past 1-2 years 92 87.6% 6 5.7% --- 
In the past 3-6 years 13 12.4% 5 4.8% 
Didn't do the Test 0 0.0% 94 89.5% 
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5.6 Family History 
Table 5.16 shows that (37.1%) of our cases and (15.2%) of our controls were born for 
parents who had a family relationship of some kind before marriage. Being a multiple birth 
sibling was more in the control group (28.6%) compared to (16.2%) in the cases. History 
of CRC in the family was in (8.6%) of cases and in (1.9%) of controls. In the other family 
cancers section, (12.4%) of the cases and (2.9%) of the controls have a family member 
whom was diagnosed with cancers other than CRC. 
Comparing study cases and control group, table 5.16 reveals that there are statistically 
significant differences (P<0.05) in the consanguinity, multiple birth siblings, and family 
history of CRC and other cancers.  
Table 5.16:  Association between study cases and control group by Family history 
Variable 
Study Cases 
N=105 
Control Group 
N=105 
P Value of 
Chi 
Square Count  N % Count  N % 
Consanguinity Not Related 66 62.9% 89 84.8% <0.0001 
Related 39 37.1% 16 15.2% 
Are you a twin, triplet 
or other multiple birth 
siblings? 
Twin or other multiple 17 16.2% 30 28.6% 0.031 
No 88 83.8% 75 71.4% 
Family colorectal 
cancer 
Yes 9 8.6% 2 1.9% 0.030 
No 96 91.4% 103 98.1% 
Relation with family 
colorectal cancer 
patient 
First degree relative 6 5.7% 1 1.0% 0.090 
Second degree relative 3 2.9% 1 1.0% 
No cancer 96 91.4% 103 98.1% 
Other family cancers Yes 13 12.4% 3 2.9% 0.009 
No 92 87.6% 102 97.1% 
Type of other family 
cancers 
Lung Cancer 2 1.9% 1 1.0% 0.029 
Other Cancers 11 10.5% 2 1.9% 
No other Family Cancers 92 87.6% 102 97.1% 
Relationship with 
family other cancer 
patient 
First degree relative 9 8.6% 2 1.9% 0.034 
Second degree relative 4 3.8% 1 1.0% 
No other family cancers 92 87.6% 102 97.1% 
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5.7 Lifestyle factors 
5.7.1 Smoking 
Table 5.17 shows that (24.8%) of our cases are smokers compared to (9.5%) of our 
controls. (84.6%) of the smoking cases compared to (90%) of the smoking controls are 
current smokers. Most of our smoking cases and controls started smoking at childhood 
(57.7%) and (66.7%) respectively. Manufactured cigarettes were the most used type of 
smoking followed by hand rolled cigarettes.  
Comparing study cases and control group, table 5.17 reveals that there are statistically 
significant differences (P<0.05) in the Smoking, Smoking status, age of smoking initiation, 
years since smoking started, and type of smoking. Pipe full of tobacco, cigars and non-
smoked tobacco products were found to be non-significant can be found in the appendix 
Table 5.17:  Association between study cases and control group by Smoking 
Variable Study cases 
N=105 
Control group 
N=105 
P value 
of chi 
square Count N % Count N % 
Smoking No 79 75.2% 95 90.5% 0.003 
Yes 26 24.8% 10 9.5% 
Current Smoker No 83 79.0% 96 91.4% 0.011 
Yes 22 21.0% 9 8.6% 
Age of Smoking 
initiation 
Childhood 15 14.3% 6 5.7% 0.014 
Adulthood 11 10.5% 4 3.8% 
Don't smoke 79 75.2% 95 90.5% 
Years since 
smoking started 
<20 years ago, 3 2.9% 3 2.9% 0.007 
≥ 20 years ago, 23 21.9% 7 6.7% 
Don't smoke 79 75.2% 95 90.5% 
Manufactured 
cigarettes smoked 
(Weekly) 
<100 cigarettes 16 15.2% 4 3.8% 0.008 
≥100 cigarettes 10 9.5% 6 5.7% 
Don't smoke 79 75.2% 95 90.5% 
Hand-Rolled 
Cigarettes 
smoked (Weekly) 
<20 cigarettes 5 4.8% 2 1.9% 0.045 
≥ 20 cigarettes 7 6.7% 1 1.0% 
Don't smoke 93 88.6% 102 97.1% 
Shisha sessions 
smoked (Weekly) 
<3 sessions 8 7.6% 4 3.8% 0.492 
≥3 sessions 3 2.9% 3 2.9% 
Don't smoke 94 89.5% 98 93.3% 
Quit smoking last 
12 months 
No 8 7.6% 2 1.9% 0.019 
Yes 14 13.3% 6 5.7% 
I don't smoke 83 79.0% 97 92.4% 
Advice to quit 
smoking from 
doctor 
No 4 3.8% 1 1.0% 0.010 
Yes 8 7.6% 5 4.8% 
No doctor visits in 
the past 12 months 
14 13.3% 3 2.9% 
Don't Smoke 79 75.2% 96 91.4% 
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5.7.2 Diet 
Table 5.18 shows that (87.6%) of the controls compared to (49.5%) of the cases consume 
fruit meals twice or more a week. It also shows that (69.5%) of the cases and (86.7%) of 
the controls consume vegetable meals twice a week or more. Consumption of red meat 
weekly was lower than fruits and vegetables with (53.3%) of the cases compared to 
(37.1%) of the controls whom eat two or more meals of red meat weekly. If the red meat 
was grilled the consumption of it also lowers with (49.5%) of the cases compared to 
(30.5%) of the controls whom eat grilled red meat twice or more weekly. Eating two or 
more meals of chicken weekly was more in controls (54.3%) in comparison to (48.6%) in 
the cases. Most of our cases and controls preferred the outside appearance of the red meat 
and chicken to be lightly browned, while they preferred the inside appearance of the red 
meat to brown (well done).  
Comparing study cases and control group table 5.18 shows that there are statistically 
significant differences (P<0.05) in the Fruit, Vegetables, Red meat, and Grilled red meat 
consumption between cases and controls. While Chicken didn’t show any significance. 
Table 5.18:  Association between study cases and control group by Diet 
 
Variable Study cases 
N=105 
Control Group 
N=105 
P value 
of chi 
Square Count  N % Count  N % 
Fruit <2 Weekly 53 50.5% 13 12.4% 0.000 
≥2 Weekly 52 49.5% 92 87.6% 
Vegetables <2 Weekly 32 30.5% 14 13.3% 0.003 
≥2 Weekly 73 69.5% 91 86.7% 
Red Meat <2 Weekly 49 46.7% 66 62.9% 0.018 
≥2 Weekly 56 53.3% 39 37.1% 
Grilled Red Meat <2 Weekly 53 50.5% 73 69.5% 0,005 
≥2 Weekly 52 49.5% 32 30.5% 
Red Meat outside 
appearance 
Lightly browned 71 67.6% 80 76.2% 0.512 
Medium browned 22 21.0% 16 15.2% 
Heavily browned 
or blackened 
5 4.8% 5 4.8% 
Don't eat grilled 
red meat 
7 6.7% 4 3.8% 
Red Meat inside 
appearance 
Red 45 42.9% 55 52.4% 0.057 
Pink 9 8.6% 16 15.2% 
Brown 45 42.9% 27 25.7% 
I don't eat red meat 6 5.7% 7 6.7% 
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Table5.18….Continues 
Variable Study cases 
N=105 
Control Group 
N=105 
P value 
of chi 
Square Count  N % Count  N % 
Chicken <2 Weekly 54 51.4% 48 45.7% 0.686 
≥2 Weekly 51 48.6% 57 54.3% 
Grilled Chicken <2 Weekly 94 89.5% 88 83.8% 0.223 
≥2 Weekly 11 10.5% 17 16.2% 
Chicken outside 
appearance 
Lightly browned 76 72.4% 88 83.8% 0.134 
Medium browned 21 20.0% 12 11.4% 
Heavily browned 
or blackened 
0 0.0% 0 0.0% 
Don't eat grilled 
chicken 
8 7.6% 5 4.8% 
 
 
 
5.7.3 Physical Activity 
We used WHO’s Global Physical activity questionnaire (GPAQ) to collect physical 
activity data from our study’s participants. METs (Metabolic Equivalents) are commonly 
used to express the intensity of physical activities performed. The formula we used to 
measure the MET-min/Week includes the resting hours in each week. 
Table 5.19 concludes that the control group had no significant difference in the average 
MET-min\Week. However, Table 5.20 showed that when physical activity was classified 
as groups (low physical activity group and moderate physical activity), cases had lower 
physical activity (96.2%) compared to controls (86.7%). Even though, there was no 
subjects that had high physical activity or no physical activity at all. 
The table also shows that there are statistically significant differences (P<0.05) between 
cases and control group in Physical activity. 
 
Table 5.19:  MET-mins/Week of the study subjects 
Variable 
N Mean 
Std. 
Deviation 
Std. Error 
Mean 
P value  
T test 
Physical 
activity 
MET-
Mins/Week 
Study Cases 105 251.91 164.370 16.041 0.287  
Control 
Group 
105 277.99 188.854 18.430 
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Table 5.20:  Association between study cases and control group by Physical activity 
Variable 
Study Cases Control Group P value of 
Chi 
Square Count  N % Count  N % 
Physical 
Activity 
Low Physical 
Activity (<600 
MET-Min/Week) 
101 96.2% 91 86.7% 
0.014 
Moderate Physical 
Activity (600-1500 
MET-Min/Week) 
4 3.8% 14 13.3% 
 
 
 
5.3 Multivariate analysis 
All the significant variables at (p<0.05) in the univariate analysis were included in the 
multivariate analysis except for the variables with small numbers such as family history of 
CRC, other family cancers, relationship with family CRC or other cancers and other 
smoking variables. 
Table 5.21 shows that living in villages was protective against CRC risk compared to cities 
and camps. It also shows that living in the southern area of the West Bank increases the 
risk of CRC by 1243% in comparison to the northern region of the West Bank. The analysis 
shows that consanguinity is a risk factor for CRC and increases its risk by 288%. On the 
other hand, being a multiple birth sibling, consuming fruits and taking aspirin all showed 
a protective pattern against CRC. In spite of that, smoking showed high risk for CRC with 
550% increase in risk among smokers compared to non-smokers. Consuming grilled red 
meat twice or more weekly, was also associated with increased risk of CRC by 280% 
compared to those who consume less. 
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Table 5.21: Multivariate Forward conditional model analysis of the associated 
variables with colorectal cancer* 
 
Variable Sig. AOR** 95% CI*** 
Lower Upper 
Residence City   Ref Ref 
Village .212 .343 .064 1.841 
Camp .619 1.536 .283 8.331 
Area of residence Middle region   Ref Ref 
Southern region .001 12.439 2.724 56.809 
Consanguinity Not Related   Ref Ref 
Related .021 2.887 1.171 7.118 
Are you a twin, triplet or other 
multiple birth siblings? 
Twin or other 
multiple 
  Ref Ref 
No .010 .282 .109 .735 
Smoking No   Ref Ref 
Yes .002 5.503 1.866 16.227 
Fruit <2 Weekly   Ref Ref 
≥2 Weekly .000 .082 .032 .206 
Grilled Red Meat ≥2 Weekly   Ref Ref 
<2 Weekly .010 2.847 1.289 6.287 
Aspirin No   Ref Ref 
Yes .003 .248 .099 .621 
*All variables that were significant (p<0.05) in univariate analysis were included in a 
multivariate model (P value 0.05): i.e. Residence, area of residence, Consanguinity, 
Aspirin (intake, frequency, and duration), smoking, diet, and physical activity**Adjusted 
odds ratio. ***Confidence interval. 
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Chapter Six: Discussion, conclusion and recommendations 
 
6.1. Introduction 
In this chapter, study results are summarized and compared to other studies results 
worldwide. Also, the results are interpreted and discussed. In the final part of the chapter 
study conclusions and recommendations are presented.  
 
6.2 Summary of the results 
The univariate analysis of the study data showed significant differences between study 
cases and control group in residence, area of residence, and yearly income. It also showed 
significance in Aspirin (intake, frequency, and duration). In the health status section 
diabetes and dyslipidemia didn’t show any significance between cases and controls.  
In the lifestyle, smoking, years of smoking, consuming fruit, vegetables, red meat, grilled 
red meat, and physical activity also showed significance in the univariate analysis. Family 
history of cancers, family history of colorectal cancer, and consanguinity were significant.  
On the other hand, the multivariate analysis of the study data showed that living in the 
villages lowers the risk of CRC compared to living in cities or camps. Living in the 
southern region of the West Bank increases the risk of CRC by 12 folds compared to the 
middle region of the West Bank. Also smoking increases the risk of CRC by 5.5 folds. 
Consuming fruits, grilled red meat, and taking aspirin lowers the risk of CRC. 
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6.3 Socio-demographic variables and colorectal cancer 
Gender: Males composed (54.6%) of our study sample and gender was matched between 
cases and controls to eliminate any confounding effect gender may cause to the study 
results. Despite that, literature states that CRC occurs more in females, and females are at 
more risk of developing CRC than males (Betes et al., 2003; Kolligs et al., 2011; Regula 
et al., 2006; Rex et al., 1993).  
Residence: Our study showed no statistical significance in the residence section, but it 
showed difference in the risk levels in its sub-categories villages, camps and cities. The 
risk of CRC was inversely associated with living in villages compared to camps and cities. 
However, this result is inconsistent with results revealed by other studies that living in rural 
areas increase the risk of colorectal cancer (Kinney, Harrell, Slattery, Martin, & Sandler, 
2006; Zahnd et al., 2018). Those studies stated that living in the rural areas increase cancer 
risk due to lack of screening behaviors and due to increased modifiable risk factors in those 
populations compared to the urban areas. In our study this decreased risk may be due to 
the lifestyle of the people living in the villages compared to the other areas. The villager’s 
lifestyle in Palestine is healthier compared to other areas. A cross sectional study was 
conducted in Jordan, Lebanon, Syria, and Palestine showed that smoking in the rural areas 
is low compared to urban areas (Abdulrahim & Jawad, 2018). Also, the people in the 
villages work mostly in farming which needs more physical activity and physical activity 
lowers the risk of CRC as literature indicated (Aicr & WCRF, 2007; Golshiri et al., 2016; 
Morikawa et al., 2013; Slattery et al., 2003; Thune & Lund, 1996; Wolin et al., 2010). 
Dietary patterns in the Palestinian villages are healthier and based on more natural foods 
and its main source is from their harvest or the animals they pet. A study was conducted 
on the dietary patterns of the Palestinian population in 1999 showed that villages rely most 
on their animal and their food is more natural (Stene et al., 2000). This also could explain 
this protective pattern in the villages compared to camps and cities. 
Area of residence: Our study showed that living in the southern area of the West Bank 
increases the risk of CRC by 12 folds when compared to people living in the middle region 
of the West Bank. This result is consistent with the Palestinian cancer report that indicates 
that cancer is more spread in the southern regions of Palestine compared to the middle and  
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northern regions (Abu-Rmeileh et al., 2016). No study indicated the reason of this cancer 
spread in the south. This high increased risk in our study is because 77.8% of our cases and 
97.8% of our controls are from the southern region. It is also because of the high population 
of the southern governorates which comprise almost half of the Palestinian population 
(PHIC,2016). 
6.4 Lifestyle variables and colorectal cancer 
Smoking: The univariate analysis of our study shows that about 25% of our cases were 
smokers compared to 9.5% of the control group were also smokers. Smoking showed effect 
in the occurrence of CRC in both univariate and multivariate analysis. Our study showed 
that smoking increases the risk of colorectal cancer by 5.5 folds. This result is consistent 
with literature and international studies. Two case control studies conducted to determine 
the relationship between smoking and CRC one in the US (Zhao et al., 2010) and one in 
Germany (Verla-Tebit et al., 2006),  showed that smoking increases the risk of CRC. The 
results were also consistent with two prospective cohort studies of (Hannan et al., 2009, 
and Parajuli et al., 2014). 
Diet: In the diet section, fruit and grilled red meat consumption were the only categories 
that showed significance in our study. Consuming two or more meals of fruits weekly was 
negatively associated with the risk of CRC, meaning that it lowers the risk of CRC by 82%. 
This result is consistent with the literature (Nashar & Almurshed, 2008; van Duijnhoven et 
al., 2009; Vogtmann et al., 2013) which concludes that consuming fruits and vegetables 
lowers the risk of CRC. 
Our findings also showed that consuming two or more meals of grilled meat weekly 
increases the risk of CRC by 2.8 folds. This result is consistent with the literature that 
supports that grilled meat increases the CRC risk. Literature (Bener & Bener, 2011; Cross 
& Sinha, 2004; Joshi et al., 2015; Kotake et al., 1995; Potera, 2016). Also literature 
suggests that grilling meat releases carcinogens that increases the risk of cancers (Potera, 
2016). Our result is consistent with the literature and international studies.  
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Physical activity: The physical activity in our study showed significance in the univariate 
analysis but didn’t show any in the multivariate analysis. Literature have shown that 
physical activity plays a major role in the protection against colorectal cancer (Aicr & 
WCRF, 2007; Golshiri et al., 2016; Haggar & Boushey, 2009; Slattery et al., 2003; Thune 
& Lund, 1996; Wolin et al., 2010). This insignificance in physical activity in our study is 
due to that none of our study population showed a high physical activity index per week 
and most of our population (86.7%) reported that they have a low physical activity index 
per week. This could also be attributed to that when we calculated the total MET-min/Week 
we included the resting hours and sedentary activities. In addition, it can also be attributed 
to reporting bias from the patients themselves.  
6.5 Family History, consanguinity and colorectal cancer 
Family history: Family history showed significance in the univariate analysis. It wasn’t 
included in the multivariate model because of the small numbers among cases and controls. 
Family history is known to be a strong risk factor for CRC (Beebe-Dimmer et al., 2017; 
Kotake et al., 1995; Negri et al., 1998). In our study, the number of cases and controls who 
had a positive family history to CRC or other cancers was very small. Those small numbers 
will affect the multivariate model power and are not enough to establish an association. 
Taking a look at the numbers, we notice that there is more positive family history to CRC 
or other cancers among cases compared to controls.  
Consanguinity: Our findings show that being born to a consanguineous parent increases 
the risk of developing CRC by 2.9 folds. Very few studies worldwide addressed this issue. 
A case control study in Qatar aimed to examine whether parental consanguinity affects the 
risk of cancer in a local Arab highly inbred population.  The study concluded that 
consanguinity has no effect on the overall cancers incidence(Bener et al., n.d.). This is the 
opposite to our study’s findings. This is may be due to the high rate of consanguinity 
marriage in Palestine which accounts for 44% of total registered marriages (PCBS, 2017).  
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This percentage is high compared to the surrounding countries like Jordan 23%, Egypt 
35.3%, and Lebanon 29.6% (Tadmouri et al., 2009). In our study, related parents in the 
study cases were 37.1% compared to 15.2% of the control group.  
 
Twin, triplet or other multiple birth siblings: Our results shows that being a twin or a 
multiple birth increases the risk of CRC. This result is consistent with the literature that 
stated that being a twin or a multiple birth increases the risk of cancer (Mucci et al., 2016 
; Cnattingius, Lundberg, & Iliadou, 2009). The reason for this increase in not yet known 
and all the explanations are theories and assumptions. 
 
6.5 Medications and colorectal cancer 
Aspirin: Our results show that aspirin was negatively associated with CRC risk. 
Consuming aspirin lowers the risk of CRC by almost 28%. Literature states that aspirin 
intake reduces the risk of CRC. A pooled analysis of five cardiovascular-prevention RCTs 
linked to cancer outcomes, daily aspirin use at any dose reduced the risk of CRC by 24% 
and of CRC-associated mortality by 35% after a delay of 8–10 years (Garcia-Albeniz & 
Chan, 2011). A prospective cohort study was conducted in the US to assess the risk of CRC 
and aspirin intake among 47363 men found out that regular and long-term aspirin use 
reduces risk of colorectal cancer among men (Chan et al., 2008). Other studies show the 
same outcome are mentioned in the literature review (García Rodríguez et al., 2017; Gray 
et al., 2018; Zhang et al., 2006). 
There is no policy for aspirin use or dose in Palestine. Aspirin in Palestine is prescribed for 
high risk people or people of family history of any cardiovascular diseases and given freely 
from the MOH and UNRWA. Cardiovascular diseases are the main cause of mortality in 
Palestine so there is a large high risk group of people in Palestine(PCBS, 2017), which 
suggests why so many people use it.  
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Diabetes and other diseases: Diabetes mellitus increases the risk of CRC (Deng, Gui, 
Zhao, Wang, & Shen, 2012; Tan et al., 2016). Our study showed no significance between 
CRC and diabetes. This is attributed to the close numbers of diabetic study cases and 
controls.  
Our study also showed no significance between dyslipidemia (Cholesterol and 
Triglycerides) and the risk of CRC, while literature suggests that there is an increased risk 
for CRC among dyslipidemia patients (Agnoli et al., 2014). This is may be attributed that 
the numbers were small it failed to establish a statistical significance. 
6.6 Limitations and obstacles 
Our study showed similar results compared to international studies, but there were small 
contradictions of some of the study results with other studies that may be attributed to the 
relatively small number of the studied population. In addition to some biases that might 
affect the results like information bias, recall bias, and selection bias especially in the 
variables that require memorizing such as food frequency and physical activity. The study 
was limited in terms of time and finance, which in role prohibited more investigation and 
tests. Data provided from the patient’s records was limited to oncological status of each 
patient and the lack of reporting of other medical conditions the patients have. Also, the 
medical records data was very difficult to use to calculate the survival data of the patients.  
Some limitations of this study derived from the nature of the case-control study. The 
participants were asked about their lifestyle. Most of the participants were patients who 
were under the effect of some medications, in addition to the old age of most of the 
participants, all these factors result in a recall bias.  
The reporting bias may be present in our study as some of the  participants might be  
trying either to deny the role of their lifestyle or to blame any other factors except 
themselves for their disease, so some participants answered some questions in a way to 
achieve their perception or to show that they live a better lifestyle than they do.  
Moreover, the data of family history of malignancy in the patient were missing in most of 
the cases; therefore, we could not extract reliable family history. To compensate the defect 
in participant’s medical record each participant was asked about his family history of 
colorectal cancer and this might be exposed to recall bias or information bias. 
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6.7 Conclusion 
This study is the first one in Palestine that investigated the possible association between 
different factors whether protective or risk and colorectal cancer occurrence. A case control 
study design was used to answer the study questions. The study has identified the possible 
risk factors associated Colorectal cancer patients attending the oncology department or the 
daycare clinics at Beit Jala Governmental hospital. 
Most results of this study were expected and comparable to other international studies 
results, while some others were unexpectedly contradicted the literature. Residence, area 
of residence, fruit consumption, grilled red meat consumption, aspirin consumption, 
smoking, consanguinity marriage and being a multiple birth, appeared to be associated with 
colorectal cancer either positively or negatively. Other factors showed no significance in 
our study such as vegetables consumption, red meat consumption, supplements and 
physical activity.  
 
 
6.8 Recommendations 
Recommendations for people at risk of colorectal cancer  
 Living in a healthy lifestyle that helps preventing developing diseases that increase the 
risk of CRC such as bowel diseases.  
 Increase the consumption of fruits and decrease the consumption of grilled red meat. 
Encourage people at risk to stop smoking.  
 Since low numbers of controls undergone screening so, perform a screening for 
colorectal cancer on a regular basis after the age of 40 years as age is a risk factor for CRC.  
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Recommendations for policy makers and health care team:  
 Providing more attention for colorectal cancer especially in people over 40 by policies 
designed for them.  
 Establishing national initiatives for the encouragement of early detection of colorectal 
cancer.  
 Modifying the national cancer registry to include more details related to each cancer 
type. 
 Considering colorectal cancer detection when dealing with over 40 years old patients.  
 Giving more attention to the groups at risk of colorectal cancer to enable the early 
detection.  
 Work more on the modifiable lifestyle factors which eventually affect the risk of 
colorectal cancer.  
 
 
 
Recommendations for public health researchers:  
 Conducting more detailed researches with larger sample size and including more 
hospitals and health care facilities.  
 Considering the type and the stage of colorectal cancer (histopathology) and the date of 
first diagnosis.  
  
65 
 
 
List of reference 
Abdulrahim, S., & Jawad, M. (2018). Socioeconomic differences in smoking in Jordan, 
Lebanon, Syria, and Palestine: A cross-sectional analysis of national surveys. PLOS 
ONE, 13(1), e0189829. https://doi.org/10.1371/journal.pone.0189829 
Abu-Rmeileh, N. M. E., Gianicolo, E. A. L., Bruni, A., Mitwali, S., Portaluri, M., Bitar, 
J., … Vigotti, M. A. (2016). Cancer mortality in the West Bank, Occupied 
Palestinian Territory. BMC Public Health, 16, 76. https://doi.org/10.1186/s12889-
016-2715-8 
Agnoli, C., Grioni, S., Sieri, S., Sacerdote, C., Vineis, P., Tumino, R., … Krogh, V. 
(2014). Colorectal cancer risk and dyslipidemia: A case–cohort study nested in an 
Italian multicentre cohort. Cancer Epidemiology, 38(2), 144–151. 
https://doi.org/10.1016/j.canep.2014.02.002 
Aicr, & WCRF. (2007). Diet, nutrition, physical activity and colorectal cancer. Retrieved 
from https://www.wcrf.org/sites/default/files/Colorectal-cancer-report.pdf 
Al-Shamsi, S. R., Bener, A., Al-Sharhan, M., Al-Mansoor, T. M., Azab, I. A., Rashed, 
A., … Amiri, K. M. (2003). Clinicopathological pattern of colorectal cancer in the 
United Arab Emirates. Saudi Medical Journal, 24(5), 518–522. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12847629 
American Cancer Society. (2018). Colorectal Cancer. Retrieved November 5, 2018, from 
https://www.cancer.org/cancer/colon-rectal-cancer.html 
AUVEST. (n.d.). EpiTools. Retrieved November 9, 2018, from 
http://epitools.ausvet.com.au/content.php?page=case-
controlSS&P1=0.05&RR=3&Conf=0.95&Power=0.8 
Beebe-Dimmer, J. L., Yee, C., Paskett, E., Schwartz, A. G., Lane, D., Palmer, N. R. A., 
… Simon, M. S. (2017). Family history of prostate and colorectal cancer and risk of 
colorectal cancer in the Women’s health initiative. BMC Cancer, 17(1), 848. 
https://doi.org/10.1186/s12885-017-3873-5 
Bener, A., & Bener, A. (2011). Colon cancer in rapidly developing countries: review of 
the lifestyle, dietary, consanguinity and hereditary risk factors. Oncology Reviews, 
5(1), 5. https://doi.org/10.4081/oncol.2011.5 
Bener, A., El Ayoubi, H. R., Chouchane, L., Ali, A. I., Al-Kubaisi, A., Al-Sulaiti, H., & 
Teebi, A. S. (n.d.). Impact of consanguinity on cancer in a highly endogamous 
population. Asian Pacific Journal of Cancer Prevention : APJCP, 10(1), 35–40. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19469621 
Bener, A., Habib, O. S., & Sobue, T. (2009). Cancer Epidemiology in the Arab Region 
REVIEW Cancer Epidemiology and Control in the Arab World-Past, Present and 
Future. Cancer Epidemiology in South-West Asia-Past, Present and Future Asian 
Pacific Journal of Cancer Prevention (Vol. 10). Retrieved from 
https://www.researchgate.net/publication/51443521 
66 
 
 
 
 
Betes, M., Munoz-Navas, M. A., Duque, J. M., Angos, R., Macias, E., Subtil, J. C., … 
Martinez-Gonza’lez, M. A. (2003). Use of colonoscopy as a primary screening test 
for colorectal cancer in average risk people. The American Journal of 
Gastroenterology, 98(12), 2648–2654. https://doi.org/10.1111/j.1572-
0241.2003.08771.x 
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Wu, K., & 
Fuchs, C. S. (2008). Aspirin dose and duration of use and risk of colorectal cancer in 
men. Gastroenterology, 134(1), 21–28. https://doi.org/10.1053/j.gastro.2007.09.035 
Cho, E., Lee, J. E., Rimm, E. B., Fuchs, C. S., & Giovannucci, E. L. (2012). Alcohol 
consumption and the risk of colon cancer by family history of colorectal cancer. The 
American Journal of Clinical Nutrition, 95(2), 413–419. 
https://doi.org/10.3945/ajcn.111.022145 
Cnattingius, S., Lundberg, F., & Iliadou, A. (2009). Birth characteristics and risk of 
colorectal cancer: a study among Swedish twins. British Journal of Cancer, 100(5), 
803–806. https://doi.org/10.1038/sj.bjc.6604918 
Coghill, A. E., Phipps, A. I., Bavry, A. A., Wactawski-Wende, J., Lane, D. S., LaCroix, 
A., & Newcomb, P. A. (2012). The association between NSAID use and colorectal 
cancer mortality: results from the women’s health initiative. Cancer Epidemiology, 
Biomarkers & Prevention : A Publication of the American Association for Cancer 
Research, Cosponsored by the American Society of Preventive Oncology, 21(11), 
1966–1973. https://doi.org/10.1158/1055-9965.EPI-12-0672 
Coleman, H. G., Loughrey, M. B., Murray, L. J., Johnston, B. T., Gavin, A. T., 
Shrubsole, M. J., … Cantwell, M. M. (2015). Colorectal Cancer Risk Following 
Adenoma Removal: A Large Prospective Population-Based Cohort Study. Cancer 
Epidemiology, Biomarkers & Prevention : A Publication of the American 
Association for Cancer Research, Cosponsored by the American Society of 
Preventive Oncology, 24(9), 1373–1380. https://doi.org/10.1158/1055-9965.EPI-15-
0085 
Cross, A. J., & Sinha, R. (2004). Meat-related mutagens/carcinogens in the etiology of 
colorectal cancer. Environmental and Molecular Mutagenesis, 44(1), 44–55. 
https://doi.org/10.1002/em.20030 
Cunningham, D., Atkin, W., Lenz, H.-J., Lynch, H. T., Minsky, B., Nordlinger, B., & 
Starling, N. (2010). Colorectal cancer. The Lancet, 375(9719), 1030–1047. 
https://doi.org/10.1016/S0140-6736(10)60353-4 
Deng, L., Gui, Z., Zhao, L., Wang, J., & Shen, L. (2012). Diabetes Mellitus and the 
Incidence of Colorectal Cancer: An Updated Systematic Review and Meta-Analysis. 
Digestive Diseases and Sciences, 57(6), 1576–1585. https://doi.org/10.1007/s10620-
012-2055-1 
 
67 
 
 
Freedman, L. S., Edwards, B. K., Ries, L. A. G., & Young, J. L. (2006). Cancer incidence 
in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East 
Cancer Consortium (MECC) compared with US SEER. Cancer Incidence in Four 
Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer 
Consortium (MECC) Compared with US SEER. Retrieved from 
https://www.cabdirect.org/cabdirect/abstract/20083241000 
Frezza, E. E., Wachtel, M. S., & Chiriva-Internati, M. (2006). Influence of obesity on the 
risk of developing colon cancer. Gut, 55(2), 285–291. 
https://doi.org/10.1136/gut.2005.073163 
Garcia-Albeniz, X., & Chan, A. T. (2011). Aspirin for the prevention of colorectal 
cancer. Best Practice & Research. Clinical Gastroenterology, 25(4–5), 461–472. 
https://doi.org/10.1016/j.bpg.2011.10.015 
García Rodríguez, L. A., Soriano-Gabarró, M., Bromley, S., Lanas, A., & Cea Soriano, L. 
(2017). New use of low-dose aspirin and risk of colorectal cancer by stage at 
diagnosis: a nested case-control study in UK general practice. BMC Cancer, 17(1), 
637. https://doi.org/10.1186/s12885-017-3594-9 
Golshiri, P., Rasooli, S., Emami, M., & Najimi, A. (2016). Effects of Physical Activity on 
Risk of Colorectal Cancer: A Case-control Study. International Journal of 
Preventive Medicine, 7, 32. https://doi.org/10.4103/2008-7802.175991 
Gray, R. T., Coleman, H. G., Hughes, C., Murray, L. J., & Cardwell, C. R. (2018). Low-
dose aspirin use and survival in colorectal cancer: results from a population-based 
cohort study. BMC Cancer, 18(1), 228. https://doi.org/10.1186/s12885-018-4142-y 
Haggar, F. A., & Boushey, R. P. (2009). Colorectal cancer epidemiology: incidence, 
mortality, survival, and risk factors. Clinics in Colon and Rectal Surgery, 22(4), 
191–197. https://doi.org/10.1055/s-0029-1242458 
Halahleh, K., & Gale, R. P. (2018). Cancer care in the Palestinian territories. The Lancet. 
Oncology, 19(7), e359–e364. https://doi.org/10.1016/S1470-2045(18)30323-1 
Hannan, L. M., Jacobs, E. J., & Thun, M. J. (2009). The association between cigarette 
smoking and risk of colorectal cancer in a large prospective cohort from the United 
States. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the 
American Association for Cancer Research, Cosponsored by the American Society 
of Preventive Oncology, 18(12), 3362–3367. https://doi.org/10.1158/1055-9965.EPI-
09-0661 
Heine-Bröring, R. C., Winkels, R. M., Renkema, J. M. S., Kragt, L., van Orten-Luiten, 
A.-C. B., Tigchelaar, E. F., … Kampman, E. (2015). Dietary supplement use and 
colorectal cancer risk: A systematic review and meta-analyses of prospective cohort 
studies. International Journal of Cancer, 136(10), 2388–2401. 
https://doi.org/10.1002/ijc.29277 
Janout, V., & Kollárová, H. (2001). Epidemiology of colorectal cancer. Biomedical 
Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 
145(1), 5–10. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12415635 
 
68 
 
 
 
Joshi, A. D., Kim, A., Lewinger, J. P., Ulrich, C. M., Potter, J. D., Cotterchio, M., … 
Stern, M. C. (2015). Meat intake, cooking methods, dietary carcinogens, and 
colorectal cancer risk: findings from the Colorectal Cancer Family Registry. Cancer 
Medicine, 4(6), 936–952. https://doi.org/10.1002/cam4.461 
Kinney, A. Y., Harrell, J., Slattery, M., Martin, C., & Sandler, R. S. (2006). Rural-Urban 
Differences in Colon Cancer Risk in Blacks and Whites: The North Carolina Colon 
Cancer Study. The Journal of Rural Health, 22(2), 124–130. 
https://doi.org/10.1111/j.1748-0361.2006.00020.x 
Kolligs, F. T., Crispin, A., Munte, A., Wagner, A., Mansmann, U., & Göke, B. (2011). 
Risk of Advanced Colorectal Neoplasia According to Age and Gender. PLoS ONE, 
6(5), e20076. https://doi.org/10.1371/journal.pone.0020076 
Kotake, K., Koyama, Y., Nasu, J., Fukutomi, T., & Yamaguchi, N. (1995). Relation of 
Family History of Cancer and Environmental Factors to the Risk of Colorectal 
Cancer: A Case-control Study. Japanese Journal of Clinical Oncology, 25(5), 195–
202. https://doi.org/10.1093/oxfordjournals.jjco.a039777 
Levi, Z., Kark, J. D., Katz, L. H., Twig, G., Derazne, E., Tzur, D., … Afek, A. (2017). 
Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 
million Israeli men and women: A population-based study. Cancer, 123(20), 4022–
4030. https://doi.org/10.1002/cncr.30819 
Luo, J., Lin, H.-C., He, K., & Hendryx, M. (2014). Diabetes and prognosis in older 
persons with colorectal cancer. British Journal of Cancer, 110(7), 1847–1854. 
https://doi.org/10.1038/bjc.2014.68 
Mayoclinic. (2018). Colon cancer - Symptoms and causes - Mayo Clinic. Retrieved 
November 5, 2018, from https://www.mayoclinic.org/diseases-conditions/colon-
cancer/symptoms-causes/syc-20353669 
Moghimi-Dehkordi, B., Pourhoseingholi, M., Vahedi, M., Maserat, E., Ghiasi, S., Fatemi, 
S., … Safaee, A. (2010). Risk of colorectal cancer in relatives: A case control study. 
Indian Journal of Cancer, 47(1), 27. https://doi.org/10.4103/0019-509X.58855 
Morikawa, T., Kuchiba, A., Lochhead, P., Nishihara, R., Yamauchi, M., Imamura, Y., … 
Ogino, S. (2013). Prospective Analysis of Body Mass Index, Physical Activity, and 
Colorectal Cancer Risk Associated with β-Catenin (CTNNB1) Status. Cancer 
Research, 73(5), 1600–1610. https://doi.org/10.1158/0008-5472.CAN-12-2276 
Mucci, L. A., Hjelmborg, J. B., Harris, J. R., Czene, K., Havelick, D. J., Scheike, T., … 
Nordic Twin Study of Cancer (NorTwinCan) Collaboration,  for the N. T. S. of C. 
(NorTwinCan). (2016). Familial Risk and Heritability of Cancer Among Twins in 
Nordic Countries. JAMA, 315(1), 68–76. https://doi.org/10.1001/jama.2015.17703 
Nashar, R. M., & Almurshed, K. S. (2008). Colorectal cancer: a case control study of 
dietary factors, king faisal specialist hospital and researh center, riyadh, saudi arabia. 
Journal of Family & Community Medicine, 15(2), 57–64. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/23012168 
69 
 
 
National Institutes of Health. (2006). What You Need To Know About Cancer of the 
Colon and Rectum. Retrieved from https://tccancer.org/cancer-center/wp-
content/uploads/2015/08/WYNTK_Colon.pdf 
NCI. (2018). Colon Cancer Treatment - National Cancer Institute. Retrieved May 21, 
2019, from http://www.ncbi.nlm.nih.gov/pubmed/26389319 
Negri, E., Braga, C., La Vecchia, C., Franceschi, S., Filiberti, R., Montella, M., … 
Talamini, R. (1998). Family history of cancer and risk of colorectal cancer in Italy. 
British Journal of Cancer, 77(1), 174–179. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9459165 
OCHA. (2015). Bethlehem governorate: fragmentation and humanitarian concerns. 
Retrieved from 
https://www.ochaopt.org/sites/default/files/ocha_opt_bethlehem_factSheet_03_02_2
015_english.pdf 
Okamoto, M., Shiratori, Y., Yamaji, Y., Kato, J., Ikenoue, T., Togo, G., … Omata, M. 
(2002). Relationship between age and site of colorectal cancer based on colonoscopy 
findings. Gastrointestinal Endoscopy, 55(4), 548–551. 
https://doi.org/10.1067/mge.2002.122335 
Parajuli, R., Bjerkaas, E., Tverdal, A., Le Marchand, L., Weiderpass, E., & Gram, I. T. 
(2014). Cigarette smoking and colorectal cancer mortality among 602,242 
Norwegian males and females. Clinical Epidemiology, 6, 137–145. 
https://doi.org/10.2147/CLEP.S58722 
PCBS. (2017). Preliminary Results of the Population, Housing and Establishments. 
Retrieved from http://www.pcbs.gov.ps 
Pedersen, A., Johansen, C., & Grønbaek, M. (2003). Relations between amount and type 
of alcohol and colon and rectal cancer in a Danish population based cohort study. 
Gut, 52(6), 861–867. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12740343 
Peters, U., McGlynn, K. A., Chatterjee, N., Gunter, E., Garcia-Closas, M., Rothman, N., 
& Sinha, R. (2001). Vitamin D, calcium, and vitamin D receptor polymorphism in 
colorectal adenomas. Cancer Epidemiology, Biomarkers & Prevention : A 
Publication of the American Association for Cancer Research, Cosponsored by the 
American Society of Preventive Oncology, 10(12), 1267–1274. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/11751444 
Potera, C. (2016). Red Meat and Colorectal Cancer: Exploring the Potential HCA 
Connection. Environmental Health Perspectives, 124(10), A189. 
https://doi.org/10.1289/ehp.124-A189 
Regula, J., Rupinski, M., Kraszewska, E., Polkowski, M., Pachlewski, J., Orlowska, J., … 
Butruk, E. (2006). Colonoscopy in Colorectal-Cancer Screening for Detection of 
Advanced Neoplasia. New England Journal of Medicine, 355(18), 1863–1872. 
https://doi.org/10.1056/NEJMoa054967 
 
70 
 
 
 
Rex, D. K., Lehman, G. A., Ulbright, T. M., Smith, J. J., Pound, D. C., Hawes, R. H., … 
Li, W. (1993). Colonic neoplasia in asymptomatic persons with negative fecal occult 
blood tests: influence of age, gender, and family history. The American Journal of 
Gastroenterology, 88(6), 825–831. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/8503374 
Saikali, J., Picard, C., Freitas, M., & Holt, P. (2004). Fermented Milks, Probiotic 
Cultures, and Colon Cancer. Nutrition and Cancer, 49(1), 14–24. 
https://doi.org/10.1207/s15327914nc4901_3 
Shaukat, A., Dostal, A., Menk, J., & Church, T. R. (2017). BMI Is a Risk Factor for 
Colorectal Cancer Mortality. Digestive Diseases and Sciences, 62(9), 2511–2517. 
https://doi.org/10.1007/s10620-017-4682-z 
Slattery, M. L., Edwards, S., Curtin, K., Ma, K., Edwards, R., Holubkov, R., & Schaffer, 
D. (2003). Physical activity and colorectal cancer. American Journal of 
Epidemiology, 158(3), 214–224. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12882943 
Stene, L., Giacaman, R., Abdul-Rahim, H., Husseini, A., Norum, K. R., & Holmboe-
Ottesen, G. (n.d.). Food consumption patterns in a Palestinian West Bank 
population. Retrieved from http://www.stockton-press.co.uk/ejcn 
Tadmouri, G. O., Nair, P., Obeid, T., Al Ali, M. T., Al Khaja, N., & Hamamy, H. A. 
(2009). Consanguinity and reproductive health among Arabs. Reproductive Health, 
6, 17. https://doi.org/10.1186/1742-4755-6-17 
Tan, C., Mori, M., Adachi, Y., Wakai, K., Suzuki, S., Suzuki, K., … Tamakoshi, A. 
(2016). Diabetes Mellitus and Risk of Colorectal Cancer Mortality inJapan: the 
Japan Collaborative Cohort Study. Asian Pacific Journal of Cancer Prevention : 
APJCP, 17(10), 4681–4688. https://doi.org/10.22034/APJCP.2016.17.10.4681 
Thune, I., & Lund, E. (1996). Physical activity and risk of colorectal cancer in men and 
women. British Journal of Cancer, 73(9), 1134–1140. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/8624277 
Ulrich-Pur, H., Kornek, G. V, Fiebiger, W., Gedlicka, C., Raderer, M., Lenauer, A., … 
Scheithauer, & W. (2001). Multicenter phase II trial of dose-fractionated irinotecan 
in patients with advanced colorectal cancer failing oxaliplatin-based first-line 
combination chemotherapy. Annals of Oncology (Vol. 12). Retrieved from 
https://academic.oup.com/annonc/article-abstract/12/9/1269/170844 
van Duijnhoven, F. J., Bueno-De-Mesquita, H. B., Ferrari, P., Jenab, M., Boshuizen, H. 
C., Ros, M. M., … Riboli, E. (2009). Fruit, vegetables, and colorectal cancer risk: 
the European Prospective Investigation into Cancer and Nutrition. The American 
Journal of Clinical Nutrition, 89(5), 1441–1452. 
https://doi.org/10.3945/ajcn.2008.27120 
 
 
71 
 
 
Verla-Tebit, E., Lilla, C., Hoffmeister, M., Brenner, H., & Chang-Claude, J. (2006). 
Cigarette smoking and colorectal cancer risk in Germany: A population-based case–
control study. International Journal of Cancer, 119(3), 630–635. 
https://doi.org/10.1002/ijc.21875 
Vogtmann, E., Xiang, Y.-B., Li, H.-L., Levitan, E. B., Yang, G., Waterbor, J. W., … Shu, 
X.-O. (2013). Fruit and vegetable intake and the risk of colorectal cancer: results 
from the Shanghai Men’s Health Study. Cancer Causes & Control : CCC, 24(11), 
1935–1945. https://doi.org/10.1007/s10552-013-0268-z 
Wang, Y., Yang, H., Shen, C.-J., Ge, J.-N., & Lin, J. (2017). Association between alcohol 
consumption and colorectal cancer risk. European Journal of Cancer Prevention, 
27(5), 1. https://doi.org/10.1097/CEJ.0000000000000355 
Wark, P. A., Wu, K., van ’t Veer, P., Fuchs, C. F., & Giovannucci, E. L. (2009). Family 
history of colorectal cancer: a determinant of advanced adenoma stage or adenoma 
multiplicity? International Journal of Cancer, 125(2), 413–420. 
https://doi.org/10.1002/ijc.24288 
WHO. (2012). CANCERS FACT SHEETS: COLORECTAL CANCER. Retrieved from 
http://gco.iarc.fr/today 
Wikipedia. (n.d.). Occupied Palestinian Territory: Administrative units. GeoHive. 
Retrieved from http://www.geohive.com/cntry/palestine.aspx 
Wolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., 
LaMonte, S. J., … Smith, R. A. (2018). Colorectal cancer screening for average-risk 
adults: 2018 guideline update from the American Cancer Society. CA: A Cancer 
Journal for Clinicians, 68(4), 250–281. https://doi.org/10.3322/caac.21457 
Wolin, K. Y., Patel, A. V, Campbell, P. T., Jacobs, E. J., McCullough, M. L., Colditz, G. 
A., & Gapstur, S. M. (2010). Change in physical activity and colon cancer incidence 
and mortality. Cancer Epidemiology, Biomarkers & Prevention : A Publication of 
the American Association for Cancer Research, Cosponsored by the American 
Society of Preventive Oncology, 19(12), 3000–3004. https://doi.org/10.1158/1055-
9965.EPI-10-0764 
Wu, K., Platz, E. A., Willett, W. C., Fuchs, C. S., Selhub, J., Rosner, B. A., … 
Giovannucci, E. (2009). A randomized trial on folic acid supplementation and risk 
of recurrent colorectal adenoma. The American Journal of Clinical Nutrition, 90(6), 
1623–1631. https://doi.org/10.3945/ajcn.2009.28319 
Yeh, H.-C., Platz, E. A., Wang, N.-Y., Visvanathan, K., Helzlsouer, K. J., & Brancati, F. 
L. (2012). A Prospective Study of the Associations Between Treated Diabetes and 
Cancer Outcomes. Diabetes Care, 35(1), 113–118. https://doi.org/10.2337/dc11-
0255 
Zahnd, W. E., James, A. S., Jenkins, W. D., Izadi, S. R., Fogleman, A. J., Steward, D. E., 
… Brard, L. (2018). Rural–Urban Differences in Cancer Incidence and Trends in the 
United States. Cancer Epidemiology Biomarkers & Prevention, 27(11), 1265–1274. 
https://doi.org/10.1158/1055-9965.EPI-17-0430 
 
72 
 
 
Zhang, S. M., Moore, S. C., Lin, J., Cook, N. R., Manson, J. E., Lee, I.-M., & Buring, J. 
E. (2006). Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk 
in women. American Journal of Epidemiology, 163(2), 108–115. 
https://doi.org/10.1093/aje/kwj016 
Zhao, J., Halfyard, B., West, R., Buehler, S., Sun, Z., Squires, J., … Wang, P. P. (2010). 
Tobacco Smoking and Colorectal Cancer: A Population-based Case-control Study in 
Newfoundland and Labrador. Can J Public Health, 101(4), 281–289. 
https://doi.org/10.17269/CJPH.101.1941 
  
73 
 
Appendices 
Appendix 1: Approval letter from the Palestinian MOH.  
 47
 
 mrof tnesnoc stnapicitrap ydutS: 2 xidneppA
 
 الدراسات العليا
 كلية الصحة العامة 
 ماجستير صحة عامة 
 عنوان البحث: محددات سرطان القولون والمستقيم عند مرضى السرطان في مستشفى بيت جالا الحكومي 
دقيقة تقريبا. إذا كنت لا ترغب في المشاركة بالدراسة لا تتردد بقول  03شكرا على وقتك. سيتطلب استكمال الاستبيان 
لتي تتلخص في معرفة محددات سرطان القولون ذلك. هذا الاستبيان هو عبارة عن اداه لتحقيق اهداف الدراسة وا
والمستقيم في المرضى اللذين يتعالجون في مستشفى بيت جالا الحكومي. ومن خلال ذلك نسعى لفهم أفضل للعلاقة بين 
عوامل الخطر المختلفة وعلاقتها بسرطان القولون والمستقيم في المجتمع الفلسطيني ولماذا نسب هذا السرطان عالية 
 ين مقارنة بالدول المحيطة.في فلسط
 اقرا التالي بتمعن ثم وقع باخر الورقة:
إذا كنت تحتاج أي توضيح لا تتردد بسؤال الباحث. كن متأكدا ان جميع اجاباتك ومعلوماتك ستكون سرية ولن تنشر او 
 تعطى لأي أحد. لأغراض الدراسة انه لمن الضروري ان توافق على التالي:
 قرات المعلومات واني افهم هدف هذا البحث.أؤكد على انني  -
 اعطي الاذن للحصول على معلوماتي من قبل الباحث. -
 اعطي الاذن للباحث لاستخدام ملفي الطبي لأغراض الدراسة. -
 افهم انه لا يوجد أي مخاطر من المشاركة بهذه الدراسة. -
 افهم انه لا يوجد أي فوائد من المشاركة بهذه الدراسة. -
 تراك بهذه الدراسة هو تطوعي وغير اجباري.افهم ان الاش -
 توقيعي بالأسفل يعني انني موافق على المشاركة بالدراسة. -
 اعلم انني أستطيع الانسحاب من الدراسة وقتما اشاء من دون أي مشاكل.  -
 التوقيع: ____________________
 التاريخ: ____________________
 رقم ملف المريض: _____________
 moc.liamtoh@6002gki_assiوايميل :  1848249950جوال : : عيسى خالد غروز الباحث
 اشراف : د. نهى الشريف 
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  مريض 0
  ضابط 1
 هل انت؟
 
 
 
 معلومات المريض 
 الأسئلــة الاستجابة الترميز
 1A
 ذكر 0 
 انثى 1
 الجنس
  
 2A
  ┘─┴─┴─┴─└ ┘─┴─└ ┘─┴─└
 يومشهرسنة
 ما هو تاريخ ميلادك ؟
 9999 99 99اذا لا تعلم 
 كم عمرك ؟ سنوات ┘─┴─└ 3A
 4A
 لم ادرس بمدرسة  0
 اقل من الابتدائية  1
 المدرسة الابتدائية  2
 المدرسة الثانوية  3
 توجيهي 4
 شهادة دبلوم/ جامعة  5
 دراسات عليا  6
 ارفض الإجابة  99
 ما هو اعلى مستوى تعليمي وصلت له ؟
 القسم أ : معلومات المريض 
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 5A
 غبر متزوج  0
 متزوج  1
 منفصلين  2
 مطلق 3
 أرمل  4
 ارفض الإجابة  99
 الحالة الاجتماعية 
 6A
 موظف حكومي 0
 موظف غير حكومي  1
 عمل خاص  2
 غير مدفوع الاجر  3
 طالب 4
 اعمل في المنزل  5
 متقاعد  6
 عاطل عن العمل (قادر على العمل) 7
 عاطل عن العمل (غير قادر على العمل) 8
 ارفض الإجابة  99
 شهر الماضية؟ 21أي من التالي يصف عملك خلال ال 
 ما هو عملك؟ ------------------------- 7A
 8A
 بالسنة    ┘─┴─┴─┴─┴─┴─┴─└
 99ارفض الإجابة  
 ما هو معدل دخلك السنوي خلال العام الماضي؟
 9A
 مدينة  0
 قرية  1
 مخيم  2
 لا اعرف  99
 هل تعيش في؟
 مكان السكن ؟ -------------------- 01A
 11A
 لا قرابة  0
أقرباء درجة أولى (أبناء عم، أبناء عمة، أبناء  1
 خالة)
 من نفس عائلة الام او الاب  2
 لا اعلم  99
 يوجد صلة قرابة بين والدك ووالدتك ؟هل 
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 21A
 نعم  0
 لا 1
 لا اعلم  99
 هل انت توأم او توأم ثلاثي ؟
 
 
 القسم ب : التاريخ الطبي
 
 التاريخ الطبي
 السؤال  الاستجابة  الترميز
 1B
 نعم  0
 2B (لا (اذهب ل 1
 2B ((اذهب للا اعرف  99
 هل سبق وقمت بعمل فحص للدم في البراز (الدم المخفي بالبراز)؟
 a1B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 
 متى كانت اول مرة عملت فيها هذا الفحص؟
 b1B
 للكشف عن مشكلة جديدة  1
 تاريخ عائلي بوجود سرطان القولون 2
 فحص روتيني  3
 لمتابعة مشكلة سابقة  4
 --------غير ذلك  5
 لا اعرف  99
 ما هو السبب او الأسباب التي جعلتك تقوم بالفحص؟ (اختار المناسب)
 c1B
 عدد المرات ┘─┴─└
 (2Bاذا مرة واحدة فقط اذهب ل)
 99 لا اعرف 
 كم مرة قمت بعمل هذا الفحص؟
 d1B
 العمر ┘─┴─└و 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اخر مرة قمت فيها بعمل هذا الفحص ؟
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 2B
 نعم  0
 4B (لا (اذهب ل 1
 ) 4Bلا اعرف (اذهب ل 99
 هل سبق وقمت يعمل منظار للقولون ؟
 a2B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 
 اول مرة عملت فيها هذا الفحص؟متى كانت 
 b2B
 للكشف عن مشكلة جديدة  1
 تاريخ عائلي بوجود سرطان القولون 2
 فحص روتيني  3
 لمتابعة مشكلة سابقة  4
 --------غير ذلك  5
 لا اعرف 99
 ما هو السبب او الأسباب التي جعلتك تقوم بالفحص؟ (اختار المناسب)
 c2B
 عدد المرات ┘─┴─└
 (4Bواحدة فقط اذهب لاذا مرة )
 99  لا اعرف 
 كم مرة قمت بعمل هذا الفحص؟
 d2B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 مرة عملت فيها هذا الفحص؟ خرمتى كانت ا
 3B
 نعم  0
 5B (لا (اذهب ل 1
 ) 5Bلا اعرف (اذهب ل 99
هل اخبرك طبيبك يوما انه يوجد لديك لحميات في قولونك لو في 
 المستقيم ؟
 a3B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اول مرة اخبرك طبيبك بذلك ؟
 
 b3B
 نعم  0
 c4B (لا (اذهب ل 1
 ) c4Bلا اعرف (اذهب ل 99
 لحميات بالقولون او المستقيم اكثر من مرة ؟هل اخبرك طبيبك بان لديك 
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 c3B
 حميدة  1
 ممكن ان تصبح سرطانية   2
 خبيثة  3
 -------غير ذلك  4
 لا اعرف  99
 هل كنت تعرف ما نوع تلك اللحميات ؟
 d3B
 نعم  0
 5B (لا (اذهب ل 1
 ) 5Bلا اعرف (اذهب ل 99
 هل فمت بإزالة تلك اللحميات؟
 )1(d3B
 نعم  0
 لا  1
 لا اعرف  99
 هل فمت بإزالة االلحميات اكثر من مرة واحدة ؟
 4B
 نعم  0
 6B (لا (اذهب ل 1
 ) 6Bلا اعرف (اذهب ل 99
 هل اخبرك طبيبك يوما انك تعاني من مرض يسمى داء السلائل ؟
( هي حالة تحصل بعض الأحيان في العائلات بحيث يعاني الشخص من 
 القولون )كثير من الأورام في 
 a4B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اول مرة اخبرك طبيبك انك تعاني من مرض داء السلائل ؟
 5B
 نعم  0
 7B (لا (اذهب ل 1
 ) 7Bلا اعرف (اذهب ل 99
 هل اخبرك طبيبك يوما انك تعاني من مرض كرون ؟
 a5B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اول مرة اخبرك طبيبك انك تعاني من مرض كرون ؟
 6B
 نعم  0
 8B (لا (اذهب ل 1
 ) 8Bلا اعرف (اذهب ل 99
 هل اخبرك طبيبك يوما انك تعاني من التهاب القولون التقرحي ؟
 08
 
 a6B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
متى كانت اول مرة اخبرك طبيبك انك تعاني من التهاب القولون 
 التقرحي ؟
 7B
 نعم  0
 9B (لا (اذهب ل 1
 ) 9Bلا اعرف (اذهب ل 99
 هل اخبرك طبيبك يوما انك تعاني من القولون العصبي ؟
 a7B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اول مرة اخبرك طبيبك انك تعاني من القولون العصبي ؟
 8B
 نعم  0
 01B (لا (اذهب ل 1
 ) 01Bلا اعرف (اذهب ل 99
 هل اخبرك طبيبك يوما انك تعاني من داء الرتوج ؟
 a8B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اول مرة اخبرك طبيبك انك تعاني من داء الرتوج ؟
 9B
 نعم  0
 11B (لا (اذهب ل 1
 ) 11Bلا اعرف (اذهب ل 99
 هل سبق وقمت بعمليه ازاله للأمعاء الغليظة لو القولون او جزء منها ؟
 a9B
 تم ازالته كاملا  1
 إزالة جزء منه فقط  2
 لا اعرف  99
 بإزالة الأمعاء الغليظة او القولون كاملا ام جزء منه ؟هل قمت 
 b9B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اول مرة قمت بإزالة قولونك او امعاءك الغليظة ؟ 
 c9B
 نعم  0
 لا  1
 لا اعرف  99
 او امعاءك الغليظة اكثر من مرة ؟ هل قمت بإزالة قولونك
 18
 
 01B
 نعم  0
 21B (لا (اذهب ل 1
 ) 21Bلا اعرف (اذهب ل 99
 هل سبق وقمت بإزالة المرارة ؟
 a01B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى قمت بإزالة المرارة ؟
 
 11B
 نعم  0
 31B (لا (اذهب ل 1
 ) 31B(اذهب للا اعرف  99
 هل اخبرك طبيبك انك تعاني من مرض السكري ؟
 a11B
 العمر ┘─┴─└او 
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 متى كانت اول مرة اخبرك طبيبك انك تعاني من السكري ؟
 b11B
 نعم  0
 31B (لا (اذهب ل 1
 ) 31Bلا اعرف (اذهب ل 99
 مرض السكري ؟هل تأخذ ادوية للتحكم في 
 
كم المدة بالمجموع كنت  الرمز 
تأخذ بها  هذا الدواء 
 بانتظام ؟
هل كنت تأخذه بانتظام قبل 
 سنتين ؟
عندما كنت تأخذ هذا الدواء، كم 
 مرة كنت تأخذه ؟
 ما نوع الدواء الذي تأخذه ؟
 حبوب ؟ )1(c11B
 
 اشهر  --------
 سنوات  --------
 لا اعرف  99
 حبوب ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 حبوب ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف   99
 حبوب ؟
 نعم  0
 لا (اذهب للواء التالي) 1
لا اعرف ( اذهب للدواء  99
 التالي)
 حقن انسولين ؟ )2(c11B
 
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 حقن انسولين ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 ا حقن انسولين ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 حقن انسولين ؟
 نعم  0
 لا (اذهب للواء التالي) 1
اعرف ( اذهب للدواء لا  99
 التالي)
 28
 
 لا اعرف   99 
 مضخة انسولين ؟ )3(c11B
 
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 مضخة انسولين ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 مضخة انسولين ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف   99
 مضخة انسولين ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 
 
 نعم  0 21B
 41B (لا (اذهب ل 1
 ) 41Bلا اعرف (اذهب ل 99
 هل اخبرك طبيبك يوما انك تعاني من ارتفاع الكوليسترول ؟
 العمر ┘─┴─└او  a21B
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
متى كانت اول مرة اخبرك بها طبيبك انك تعاني من ارتفاع 
 الكوليسترول ؟
 نعم  0 b21B
 لا  1
 لا اعرف 99
 
 هل تأخذ علاجا للتحكم في مستوى الكوليسترول ؟ 
 نعم  0 31B
 51B (لا (اذهب ل 1
 ) 51Bلا اعرف (اذهب ل 99
 الدهون الثلاثية ؟هل اخبرك طبيبك يوما انك تعاني من ارتفاع في 
 العمر ┘─┴─└او  a31B
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
متى كانت اول مرة اخبرك بها طبيبك انك تعاني من ارتفاع في الدهون 
 الثلاثية ؟
 نعم  0 b31B
 لا  1
 لا اعرف 99
 
 هل تأخذ علاجا للتحكم في مستوى الدهون الثلاثية ؟
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 نعم  0 11B
 d51B (لا (اذهب ل 1
 ) d51Bلا اعرف (اذهب ل 99
 هل اخبرك طبيبك يوما انك تعاني من السرطان ؟
 ---------الأول  a41B
 ---------الثاني 
 لا اعرف  99
 ما كان نوع ذلك السرطان ؟
 العمر ┘─┴─└او  b41B
 السنة ┘─┴──┴─└او
 قبل سنوات ┘─┴─└ او 
 99 لا اعرف 
 طبيبك انك تعاني من هذا النوع من السرطان ؟متى اخبرك 
 نعم  0 c41B
 لا  1
 لا اعرف 99
 
 هل تم علاجك باستخدام الاشعة ؟ (تشمل كافة أنواع الاشعة )
 
 
 
 
 نعم  0 d41B
 لا  1
 لا اعرف 99
 هل سبق وخضعت لعملية زراعة نخاع عظم ؟
 نعم  0 51B
 لا  1
 لا اعرف 99
افراد عائلتك بسرطان القولون او هل سبق وان تم تشخيص احد 
 المستقيم ؟
 قرابة درجة أولى0 a51B
 قرابة درجة ثانية 1
 لا اعرف 99
ما صلة القرابة اللي تجمعك مع الشخص الذي تم تشخيصه بسرطان 
 القولون او المستقيم ؟
 نعم  0 61B
 لا  1
 لا اعرف 99
 هل سبق وان تم تشخيص أحد افراد عائلتك باي نوع من أنواع
 السرطانات الأخرى ؟
 ----------------------- a61B
 لا اعرف 99
 ما نوع هذا السرطان 
 قرابة درجة أولى0 b61B
 قرابة درجة ثانية 1
ما صلة القرابة التي تجمعك مع الشخص الذي تم تشخيصه بسرطانات 
 أخرى ؟
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 لا اعرف 99
 
 
 
 
 السؤال الرمز
في هذا السؤال سنسالك عن بعض الادوية التي ربما اخذتها. نحن فقط نهتم بالأدوية التي اخذتها وانت بالغ ليست تلك التي  71B
 بالطفولة 
ما هي المدة التي اخذت  
 فيها هذا الدواء بانتظام ؟
هل كنت تأخذ هذا الدواء 
 بانتظام قبل سنتين ؟
عندما كنت تأخذ هذا الدواء، كل 
 تأخذه ؟كم مرة كنت 
هل سبق واخذت احد الادوية 
التالية مرتين أسبوعيا لمدة 
 شهر او اكثر ؟
 الاسبرين بأنواعه ؟ a71B
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 الاسبرين بأنواعه ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 الاسبرين بأنواعه ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
 
 الاسبرين بأنواعه ؟
 نعم  0
 لا (اذهب للواء التالي) 1
لا اعرف ( اذهب للدواء  99
 التالي
اكامول، بانادول  b71B
 واسيتامنوفين بانواعها  ؟
 اشهر  --------
 سنوات  --------
 لا اعرف 99
اكامول، بانادول 
 واسيتامنوفين بانواعها  ؟
 نعم  0
 لا  1
 لا اعرف 99
 
اكامول، بانادول واسيتامنوفين 
 بانواعها  ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
اكامول، بانادول واسيتامنوفين 
 بانواعها  ؟
 نعم  0
 ء التالي)لا (اذهب للوا 1
لا اعرف ( اذهب للدواء  99
 التالي
مضادات الالتهاب غير  c71B
الستيرويدية مثل ايبروفين 
 وانواعه ؟
 اشهر  --------
 سنوات  --------
 لا اعرف 99
مضادات الالتهاب غير 
الستيرويدية مثل ايبروفين 
 وانواعه ؟
 نعم  0
 لا  1
 لا اعرف 99
 
مضادات الالتهاب غير 
الستيرويدية مثل ايبروفين 
 وانواعه ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
مضادات الالتهاب غير 
الستيرويدية مثل ايبروفين 
 وانواعه ؟
 نعم  0
 لا (اذهب للواء التالي) 1
اعرف ( اذهب للدواء لا  99
 التالي
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 ادوية مسهلة بأنواعها ؟ d71B
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 ادوية مسهلة بأنواعها ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 ادوية مسهلة بأنواعها ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
 ادوية مسهلة بأنواعها ؟
 نعم  0
 لا (اذهب للواء التالي) 1
لا اعرف ( اذهب للدواء  99
 التالي
 حبوب الفيتامينات ؟ e71B
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 حبوب الفيتامينات ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 الفيتامينات ؟حبوب 
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
 حبوب الفيتامينات ؟
 نعم  0
 لا (اذهب للواء التالي) 1
لا اعرف ( اذهب للدواء  99
 التالي
 حبوب حمض الفوليك ؟  f71B
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 حبوب حمض الفوليك ؟ 
 نعم  0
 لا  1
 لا اعرف 99
 
 حبوب حمض الفوليك ؟ 
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
 حبوب حمض الفوليك ؟ 
 نعم  0
 لا (اذهب للواء التالي) 1
اعرف ( اذهب للدواء لا  99
 التالي
 حبوب الكالسيوم ؟ g71B
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 حبوب الكالسيوم ؟
 نعم  0
 لا  1
 لا اعرف 99
 
 حبوب الكالسيوم ؟
 مرة في اليوم --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
 حبوب الكالسيوم ؟
 نعم  0
 لا (اذهب للواء التالي) 1
لا اعرف ( اذهب للدواء  99
 التالي
 مضادات حموضة ؟  h71B
 اشهر  --------
 سنوات  --------
 لا اعرف 99
 مضادات حموضة ؟ 
 نعم  0
 لا  1
 لا اعرف 99
 
 مضادات حموضة ؟ 
 اليوممرة في  --------
 مرة في الاسبوع --------
 مرة في الشهر --------
 مرة في السنة  --------
 لا اعرف 99
 مضادات حموضة ؟ 
 نعم  0
 لا  1
 لا اعرف  99
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 القسم ج : التدخين واستهلاك الكحوليات
 
 
 التدخين 
 السؤال الاستجابة  الرمز 
 نعم  0 1C
 ) 8Cلا (اذهب ل  1
 من منتجاته مثل السجائر، الغليون والنارجيلة ؟هل تدخن التبغ او أي 
 نعم 0 2C
 لا 1
 هل انت حاليا مدخن للتبغ او أي من منتجاته ؟ 
 ┘─┴─└ العمر بالسنوات  3C
 99  لا اعرف 
 كم كان عمرك عندما بدأت التدخين ؟
 سنوات ┘─┴─└او 4C
 اشهر ┘─┴─└او
 اسابيع┘─┴─└
 منذ متى وانت تدخن ؟
 لا اعرف  99
 كم من المنتجات التالية تدخن أسبوعيا/ يوميا ؟ يوميا↓  ↓اسبوعيا 
سجائر جاهزة      wa5C/a5C
 ┘─┴─┴─┴─└┘─┴─┴─┴─└
سجائر محضرة يدويا  wb5C/b5C
 ┴─┴─┴─└┘─┴─┴─┴─└
غليون                wc5C/c5C
 ┘─┴─┴─┴─└┘─┴─┴─┴─└
سيجار               wd5C/d5C
 ┘─┴─┴─┴─└┘─┴─┴─┴─└
نارجيلة              we5C/e5C
 ┘─┴─┴─┴─└┘─┴─┴─┴─└
غير ذلك             wf5C/f5C
 ┘─┴─┴─┴─└┘─┴─┴─┴─└
 نعم 0 6C
 لا 1
 شهر الماضية ؟ 21هل فكرت بترك التدخين خلال ال 
 نعم 0 7C
 لا 1
 شهر الماضية  21لا زيارات للطبيب خلال ال  2
شهر الماضية ، هل نصحك  21خلال زيارتك للطبيب خلال ال 
 بترك التدخين ؟
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 نعم 0 8C
 ) 21Cلا  (اذهب ل  1
 في الماضي، هل سبق وان دخنت أي نوع من أنواع التبغ ؟
 نعم 0 9C
 لا 1
 هل سبق لك وان دخنت بشكل يومي بالماضي؟
 ┘─┴─└العمر بالسنوات  01C
 لا اعرف  99
 كم كان عمرك عندما توفقت عن التدخين ؟
 سنوات┘─┴─└او  11C
 اشهر┘─┴──┴─└او
 اسابيع ┘─┴─└ او 
 99 لا اعرف 
 منذ متى وانت متوقف عن التدخين ؟
 
 
 
 نعم 0 21C
 ) 41Cلا  (اذهب ل  1
هل سبق لك وان استخدمت أي من منتجات التبغ الغير مدخنة مثل 
 الممضوغة وعلكة التبغ وغيرها؟ 
 نعم 0 31C
 لا 1
 ها تستخدم منتجات الدخان الغير مدخنة بشكل يومي ؟
 نعم 0 41C
 ) 61Cلا  (اذهب ل  1
هل سبق لك وان استخدمت أي من منتجات التبغ الغير مدخنة في 
 الماضي ؟
 نعم 0 51C
 لا 1
هل سبق لك وان استخدمت أي من منتجات التبغ الغير مدخنة بشكل 
 يومي في الماضي ؟
 نعم 0 61C
 لا 1
 يوما الماضية ، هل دخن احد داخل منزلك ؟ 03خلال ال 
 نعم 0 71C
 لا 1
 لا اعمل في منطقة مغلقة  2
يوما الماضية، هل دخن احد بقربك في منطقة مغلقة  03خلال ال 
 العمل ؟مثل 
 
 
 تناول الكحوليات
 السؤال الاستجابة  الترميز
 نعم 0 1D
 لا 1
هل سبق لك وان شربت أي مشروب كحولي مثل البيرة ، الخمرة او 
 المشروبات الروحية ؟
 نعم 0 2D
 لا 1
 شهرا الماضية ؟ 21هل شربت أي مشروب كحولي خلال ال 
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 نعم 0 3D
 لا 1
الكحوليات لأسباب صحية  او لان الطبيب هل توقفت عن شرب 
 اخبرك بذلك ؟
 يوميا      0 4D
 أيام في الأسبوع  6-5     1
 أيام في الأسبوع  4-3     2
 أيام في الأسبوع  2-1     3
 أيام في الشهر  3-1     4
 اقل من مرة في الشهر      5
فيها كاسا شهرا الماضية كم عدد المرات التي تناولت  21خلال ال 
 كحوليا واحدا ؟
 نعم 0 5D
 لا 1
 يوما الماضية ؟ 03هل شربت أي مشروب كحولي خلال ال 
 ┘─┴─└عدد 6D
 لا اعرف  99
يوما الماضية، ما عدد المناسبات التي شربت فيها  03خلال ال 
 مشروبا كحوليا واحدا على الأقل ؟
 ┘─┴─└عدد 7D
 لا اعرف 99
الماضية، ما عدد المرات التي شربت فيها مشروبا يوما  03خلال ال 
 كحوليا واحدا خلال المناسبات التي شربت فيها ؟
 ┘─┴─└اكبر عدد 8D
 لا اعرف 99
يوما الماضية، ما هو اكبر عدد من المشروبات  03خلال ال 
 الكحولية التي شربتها خلال مناسبة  واحدة ؟
 ┘─┴─└عدد 9D
 لا اعرف 99
يوما الماضية ، ما هو عدد المناسبات التي شربت فيها  03خلال ال 
 او اكثر مشروبات كحولية ؟ 6
 أيام الماضية ، كم مشروبا كحوليا شربت في اليوم ؟  7خلال ال  ┘─┴─└السبت  a01D
 ┘─┴─└الاحد  b01D
 ┘─┴─└الاثنين  c01D
 ┘─┴─└الثلاثاء  d01D
 ┘─┴─└الأربعاء  e01D
 ┘─┴─└الخميس  f01D
 ┘─┴─└الجمعة  g01D
 لا اعرف  99 
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 القسم د : التغذية
 
 التغذية
 السؤال الاستجابة الترميز
 وجية يوميا  ┘─┴─└ 1E
 وجبة أسبوعيا  ┘─┴─└
 وجبة شهريا  ┘─┴─└
 لا اعرف  99
 قبل سنة منذ تم تشخيصك بالسرطان، كم وجبة من الفواكه كنت تأكل ؟
 
 وجية يوميا  ┘─┴─└ 2E
 وجبة أسبوعيا  ┘─┴─└
 وجبة شهريا  ┘─┴─└
 لا اعرف  99
قبل سنة منذ تم تشخيصك بالسرطان، كم وجبة من الخضروات كنت 
 تأكل ؟
 
 وجية يوميا  ┘─┴─└ 3E
 وجبة أسبوعيا  ┘─┴─└
 وجبة شهريا  ┘─┴─└
 لا اكل لحوم حمراء  89
 لا اعرف  99
بالسرطان، كم وجبة من اللحم الاحمر كنت قبل سنة منذ تم تشخيصك 
 تأكل ؟
 (لا يشمل الدجاج او السمك )
 وجية يوميا  ┘─┴─└ a3E
 وجبة أسبوعيا  ┘─┴─└
 وجبة شهريا  ┘─┴─└
 لا اكل لحوم حمراء مشوية  89
 لا اعرف 99
قبل سنة منذ تم تشخيصك بالسرطان، كم وجبة من اللحم الأحمر 
 المشوي  كنت تأكل ؟
 
 بنية قليلا 0 b3E
 بنية بشكل معتدل  1
 بنية كثيرا او مسمر 2
 لا اعرف 99
 لا اكل لحما احمر مشويا  89
 
 عندما كنت تأكل لحما احمرا مشويا، كيف كان مظهرها من الخارج ؟
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 حمراء  0 c3E
 زهرية  1
 بنية  2
 لا اعرف  99
 عندما كنت تأكل لحما احمرا مشويا، كيف كان مظهرها من الداخل ؟
 وجية يوميا  ┘─┴─└ 4E
 وجبة أسبوعيا  ┘─┴─└
 وجبة شهريا  ┘─┴─└
 لا اكل الدجاج  89
 لا اعرف 99
 قبل سنة منذ تم تشخيصك بالسرطان، كم وجبة من الدجاج كنت تأكل ؟
 
 وجية يوميا  ┘─┴─└ a4E
 وجبة أسبوعيا  ┘─┴─└
 وجبة شهريا  ┘─┴─└
 لا اكل دجاج  مشوي  89
 لا اعرف 99
تم تشخيصك بالسرطان، كم وجبة من الدجاج المشوي كنت قبل سنة منذ 
 تأكل ؟
 
 بنية بشكل معتدل  1 b4E
 بنية كثيرا او مسمر 2
 لا اعرف 99
 لا اكل دجاجا مشويا  89
 
 عندما كنت تأكل دجاج مشويا، كيف كان يبدو مظهرها  ؟
 
 
 القسم ه : النشاط البدني
 
 النشاط البدني
 الأسئلــة الاستجابة الترميز
 1P
 هل نمط العمل يتوجب نشاطا شاقا يسبب زيادة كبيرة نعم 0
في التنفس وإسراع ضربات القلب مثل (الحمل الثقيل، الحفر، ورشة  
 بناء) لمدة عشرة دقائق متواصلة على الأقل؟
 لا 1 اذهب إلى  إذا لا4P
 عدد الأيام ┘─└ 2P
 كم من أيام الأسبوع العادي يتوجب عليك النشاط الشاق
  كجزء من عملك؟ 
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 3P
 )b-a(
 ┘─┴─└ :┘─┴─└
 ساعةدقيقة
 ساعةدقيقة   
 كم من الوقت في اليوم العادي تستغرق لإنجاز هذا 
 النشاط الشاق؟
 4P
 هل يشمل عملك أنشطة متوسطة الجهد التي تسبب زيادة  نعم 0
طفيفة في التنفس ونبضات القلب مثل (المشي السريع حمل أشياء خفيفة 
 لا 1  اذهب إلى إذا لا7P الوزن) لمدة عشر دقائق على الأقل؟ 
 ┘─└ 5P
 عدد الأيام
 
 كم من أيام الأسبوع العادي يتوجب عليك بذل نشاط متوسط كجزء
 من عملك ؟
 6P
 )b-a(
 ┘─┴─└ :┘─┴─└
 ساعةدقيقة
 ساعةدقيقة   
كم من الوقت في اليوم العادي يستغرق منك القيام بنشاط متوسط كجزء 
 من عملك ؟
 7P
 هل تسير على الأقدام أو تركب دراجة من وإلى أماكن معينة لمدة  نعم 0
 لا 1  ذهب إلى   إذا لا01P عشر دقائق متواصلة على الأقل؟
 عدد الأيام  ┘─└ 8P
الأسبوع العادي تستعمل الدراجة أو تسير من وإلى أماكن كم يوما ًفي 
 معينة؟
 9P
 )b-a(
 ┘─┴─└ :┘─┴─└
 ساعةدقيقة
 ساعةدقيقة   
 كم من الوقت في المجموع تستغرق للتنقل بالدراجة أو
  سيرا ًعلى الأقدام في اليوم العادي 
 01P
اللياقة البدنية هل يتضمن وقت الفراغ نشاطا ًشاقا ًسواء كان للرياضة أو  نعم 0
أو النشاط الترفيهي ويتسبب في زيادة في التنفس وعدد ضربات القلب 
 مثل (الجرى أو كرة القدم) لمدة عشرة دقائق متواصلة؟ 
 
  اذهب إلى إذا لا31P
 1
 لا
 كم يوما ًفي الأسبوع العادي تقوم بنشاط شاق كجزء من وقت فراغك؟ عدد الأيام ┘─└ 11P
 21P
 )b-a(
 :┘─┴─└
 ┘─┴─└
 ساعةدقيقة
 كم ساعة في اليوم العادي تستغرق لإنجاز هذا النشاط ؟ ساعةدقيقة   
 31P
هل يشمل وقت فراغك أنشطة متوسطة الجهد، مثل( المشي السريع ،  نعم 0
كرة اليد ) لمدة  -سباحة  –ركوب دراجة أو حمل أشياء خفيفة الوزن 
 عشر دقائق على الأقل؟
  الأمثلة والنماذج التوضيحيةاستخدم 
 لا  1 اذهب إلى  إذا لا  61P
 كم يوما ًفي الأسبوع تقوم بأنشطة معتدلة كجزء من وقت الفراغ؟ عدد الأيام ┘─└ 41P
 51P
 )b-a(
 :┘─┴─└
 ┘─┴─└
 ساعةدقيقة
 كم من الوقت تستغرق للقيام بهذا النشاط في يوم عادي؟ ساعةدقيقة   
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 61P
 )b-a(
 :┘─┴─└
 ┘─┴─└
 ساعةدقيقة
 كم من الوقت أمضيته جالسا ًأو مستلقيا ًفي اليوم العادي ؟ ساعةدقيقة   
 
 
 
 القسم و : الطول والوزن
 
 الترميز  الاستجابة السؤال
 1G سم ┘─└ .┘─┴─┴─└ الطول
 2G كغم  ┘─└ .┘─┴─┴─└ الوزن
 3G كغم ┘─└ .┘─┴─┴─└ كم كان وزنك قبل سنتين من الان 
 4G كغم ┘─└ .┘─┴─┴─└ كم كان وزنك قبل سنتين من تشخيصك بالسرطان 
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Appendix 4: Panadol, NSAIDs, Laxatives, Multivitamins, Folic Acid, Calcium, and 
Antacids tables 
 
 Study cases 
N=105 
Control Group 
N=105 
P value of Chi 
Square 
Count Column N 
% 
Count Column N 
% 
Significance 
Panadol Yes 15 14.3% 20 19.0% 0.355 
No 90 85.7% 85 81.0% 
NSAIDs Yes 11 10.5% 13 12.4% 0.664 
No 94 89.5% 92 87.6% 
Laxatives Yes 9 8.6% 4 3.8% 0.152 
No 96 91.4% 101 96.2% 
Multivitamins Yes 11 10.5% 12 11.4% 0.825 
No 94 89.5% 93 88.6% 
Folic Acid Yes 0 0.0% 2 1.9% 0.155 
No 105 100.0% 103 98.1% 
Calcium Yes 4 3.8% 10 9.5% 0.097 
No 101 96.2% 95 90.5% 
Antacids Yes 1 1.0% 2 1.9% 0.561 
No 104 99.0% 103 98.1% 
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Appendix 5: Smoking status, age of smoking initiation, years since smoking started, and 
type of smoking. Pipe full of tobacco, cigars and non-smoked tobacco products 
 Study cases Control Group P value of 
Chi Square 
Count Column 
N % 
Count Column 
N % 
Significance 
Pipe full of 
tobacco smoked 
(Weekly) 
<2 pipes 1 1.0% 0 0.0% 0.341 
≥2 pipes 1 1.0% 0 0.0% 
Don't smoke 103 98.1% 105 100.0% 
Cigar smoked 
(Weekly) 
<5 cigars 1 1.0% 2 1.9% 0.361 
≥5 cigars 4 3.8% 1 1.0% 
Don't smoke 100 95.2% 102 97.1% 
Past Smoking No 6 5.7% 2 1.9% 0.283 
Yes 7 6.7% 5 4.8% 
Non Smoker 92 87.6% 98 93.3% 
Past daily 
smoking 
No 2 1.9% 1 1.0% 0.274 
Yes 12 11.4% 6 5.7% 
Non smoker 91 86.7% 98 93.3% 
Non Smoked 
tobacco 
No 105 100.0% 104 99.0% 0.316 
Yes 0 0.0% 1 1.0% 
Non Smoked 
tobacco daily 
No 105 100.0% 104 99.0% 0.316 
Yes 0 0.0% 1 1.0% 
Ever used Non 
smoked tobacco 
No 105 100.0% 104 99.0% 0.316 
Yes 0 0.0% 1 1.0% 
Ever used Non 
Smoked tobacco 
daily 
No 105 100.0% 104 99.0% 0.316 
Yes 0 0.0% 1 1.0% 
Indoor smoking No 98 93.3% 103 98.1% 0.088 
Yes 7 6.7% 2 1.9% 
Work Smoking No 61 58.1% 75 71.4% 0.121 
Yes 26 24.8% 19 18.1% 
Don't work in a 
closed area 
18 17.1% 11 10.5% 
 
